Other infective otitis externa

H8_EXT_INFNAS

otitis externa: Inflammation of the anatomical structures of the outer ear and ear canal secondary to an infectious process. Bacterial etiology is most common, but fungal infection is also possible. Symptoms include erythema, edema, and pain.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — H60.3 Cause of death: ICD-10 — H60.3 2 out of 7 registries used, show all original rules.	2444
4. Check minimum number of events None	2444
5. Include endpoints None	2444
6. Filter based on genotype QC (FinnGen only)	2341

Control definitions (FinnGen only)

Control exclude: H8_EXTERNAL

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: H60
Name in latin: Alia otitis externa infectiosa

NAME	H8_EXT_INFNAS
CONTROL_EXCLUDE	H8_EXTERNAL
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	H603
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	H603
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other infective otitis externa based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	16526	8526	7935
Only index persons	15476	8098	7378
Unadjusted period prevalence (%)
Whole population	0.23	0.24	0.22
Only index persons	0.29	0.30	0.28
Median age at first event (years)
Whole population	46.95	45.50	48.53
Only index persons	47.01	45.65	48.51

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2341	1318	1023
Unadjusted period prevalence (%)	0.47	0.47	0.47
Median age at first event (years)	53.17	48.76	58.86

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2444: Matched controls
24440

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

H60.3

ICD-10 Finland

Other infective otitis externa

+∞

307.7

2444

102

H60

ICD-10 Finland

Otitis externa

9.9

307.7

441

531

H60.8

ICD-10 Finland

Other otitis externa

38.9

307.7

516

167

H60.9

ICD-10 Finland

Otitis externa, unspecified

20.4

307.7

898

677

H70

ICPC

Otitis externa

16.8

277.8

239

157

H66.0

ICD-10 Finland

Acute suppurative otitis media

6.7

273.3

501

912

UDC00

NOMESCO Finland

Ear microscopy

6.5

251.2

463

844

H66.9

ICD-10 Finland

Otitis media, unspecified

6.6

237.5

426

754

H01

ICPC

Ear pain/earache

5.1

234.6

607

1500

H60.5

ICD-10 Finland

Acute otitis externa, noninfective

31.9

225.2

147

H72.0

ICD-10 Finland

Central perforation of tympanic membrane

15.6

224.1

199

138

H61.2

ICD-10 Finland

Impacted cerumen

7.0

219.1

366

600

H60.1

ICD-10 Finland

Cellulitis of external ear

24.3

207.7

149

S03CA04

ATC

hydrocortisone and antiinfectives; ophthalmic, otic

10.5

201.6

231

240

Z01.1

ICD-10 Finland

Examination of ears and hearing

4.0

179.0

626

1917

H29

ICPC

Ear symptom/complaint other

4.4

175.1

526

1439

H04

ICPC

Ear discharge

8.2

168.4

236

316

H61.8

ICD-10 Finland

Other specified disorders of external ear

42.1

167.7

101

DFF00

NOMESCO Finland

Pure tone audiometry

4.5

166.8

471

1226

DC1AD

NOMESCO Finland

Temporalbone CT

20.1

162.4

126

H65.3

ICD-10 Finland

Chronic mucoid otitis media

10.4

161.4

184

189

H60.0

ICD-10 Finland

Abscess of external ear

35.2

155.1

H66.3

ICD-10 Finland

Other chronic suppurative otitis media

26.1

150.8

105

S02CA02

ATC

flumetasone and antiinfectives; otic

5.5

142.6

298

600

H62.0*A46

ICD-10 Finland

Otitis externa in erysipelas

45.2

140.2

H71

ICD-10 Finland

Cholesteatoma of middle ear

16.4

139.3

119

H90.6

ICD-10 Finland

Mixed conductive and sensorineural hearing loss, bilateral

10.3

120.2

137

140

H70.1

ICD-10 Finland

Chronic mastoiditis

44.5

109.3

H92.0

ICD-10 Finland

Otalgia

4.5

106.6

284

696

TDA90

NOMESCO Finland

Removal wax from ear

12.3

104.4

105

R5130

NOMESCO Finland

Repair work or maintenance done on the aid

6.2

103.0

185

321

Z46.1

ICD-10 Finland

Fitting and adjustment of hearing aid

4.5

97.9

261

639

S03CA01

ATC

dexamethasone and antiinfectives; ophthalmic, otic

7.4

95.4

142

202

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

2.9

94.4

546

2204

J01MA02

ATC

ciprofloxacin; systemic

2.4

92.6

1130

6503

H65.2

ICD-10 Finland

Chronic serous otitis media

10.5

90.5

101

100

DCA10

NOMESCO Finland

Paracentesis of tympanic membrane

8.7

89.2

115

138

H66.4

ICD-10 Finland

Suppurative otitis media, unspecified

16.0

88.3

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

2.3

88.3

1491

9787

DAX00

NOMESCO Finland

Adjustment or review of hearing aid

4.7

86.6

215

496

Z97.4

ICD-10 Finland

Presence of external hearing-aid

4.8

85.9

203

450

J01DB01

ATC

cefalexin; oral

3.4

82.6

2178

17294

H13

ICPC

Plugged feeling ear

2.5

70.0

571

2693

H65.0

ICD-10 Finland

Acute serous otitis media

7.3

69.7

104

148

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.7

67.5

411

1681

Z2221

NOMESCO Finland

Medical doctor

2.2

66.1

801

4454

J01DA01

ATC

[U] cefalexin

2.1

62.1

1618

11838

DCA20

NOMESCO Finland

Insertion of ventilating tube through tympanic membrane

5.5

61.3

122

232

Z3229

NOMESCO Finland

Other healthcare associate professional

3.0

57.0

282

1027

H81

ICPC

Excessive ear wax

2.4

57.0

479

2269

D07AB02

ATC

hydrocortisone butyrate; topical

2.1

56.8

810

4739

D07AC01

ATC

betamethasone; topical

2.0

56.6

962

5991

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

2.3

56.1

504

2456

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.9

54.0

1158

7771

DFF15

NOMESCO Finland

Speech audiometry

3.7

53.9

178

505

J01FF01

ATC

clindamycin; systemic

2.0

52.9

749

4351

R5120

NOMESCO Finland

Preparation of an aid

4.6

52.2

126

283

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.2

51.3

528

2713

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

4.3

50.7

134

323

H66

ICD-10 Finland

Suppurative and unspecified otitis media

5.0

50.1

111

232

DAX08

NOMESCO Finland

Fitting of hearing aid

3.5

49.9

180

541

H65.1

ICD-10 Finland

Other acute nonsuppurative otitis media

7.0

49.7

111

L30.9

ICD-10 Finland

Dermatitis, unspecified

2.1

49.3

562

3001

38110

ICD-8 Finland

Otitis media without mention of mastoiditis, Chronic

12.2

48.0

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

2.0

46.7

746

4486

H72.2

ICD-10 Finland

Other marginal perforations of tympanic membrane

16.5

46.2

H02AB06

ATC

prednisolone; systemic

1.8

46.0

1200

8425

Z3226

NOMESCO Finland

Physiotherapist

2.1

45.8

519

2755

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.9

45.7

749

4536

R5140

NOMESCO Finland

Monitoring the use of the aid

2.5

45.6

331

1458

DBD20

NOMESCO Finland

Plastic repair of external auditory canal

66.3

45.3

E0000UV, ,

ATC

1.8

45.2

1065

7235

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.3

45.1

394

1883

DCD00

NOMESCO Finland

Myringoplasty

9.8

44.9

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.9

44.5

940

6169

H66.1

ICD-10 Finland

Chronic tubotympanic suppurative otitis media

14.7

43.4

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.9

43.2

733

4477

R01AD09

ATC

mometasone; nasal

1.8

42.9

1166

8231

H02AB07

ATC

prednisone; oral

2.3

42.5

388

1885

Z71.8

ICD-10 Finland

Other specified counselling

1.9

42.5

809

5122

WX408

NOMESCO Finland

General anesthesy, balanced

1.9

41.6

680

4094

H90.0

ICD-10 Finland

Conductive hearing loss, bilateral

9.3

41.3

N02AX02

ATC

tramadol; systemic, rectal

1.8

41.3

1073

7447

J01CA04

ATC

amoxicillin; systemic

2.1

39.9

2035

17226

Z3231

NOMESCO Finland

Registered nurse

1.9

39.2

711

4411

H60.4

ICD-10 Finland

Cholesteatoma of external ear

87.6

38.9

J01DA06

ATC

[U] cefuroxime

2.1

38.0

398

2037

R4110

NOMESCO Finland

Physiotherapy

1.8

37.7

702

4382

D07XC01

ATC

betamethasone; topical

2.2

37.4

338

1631

ZXD10

NOMESCO Finland

Scheduled procedure

1.8

37.3

943

6441

J01FA10

ATC

azithromycin; systemic

1.7

37.0

1436

11035

J01FA09

ATC

clarithromycin; systemic

1.8

36.0

790

5167

XF400

NOMESCO Finland

ECG with 12 standard connections

2.1

35.4

413

2197

R03AC02

ATC

salbutamol; inhalant

1.7

35.3

1353

10305

R01AD08

ATC

fluticasone; nasal

1.8

35.2

729

4682

A46

ICD-10 Finland

Erysipelas

2.1

35.2

369

1886

DFF30

NOMESCO Finland

Loudness discomfort Level (LDL)

3.9

35.1

104

273

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.7

33.9

1349

10332

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.7

33.4

1034

7405

H90.1

ICD-10 Finland

Conductive hearing loss, unilateral with unrestricted hearing on the contralateral side

5.6

33.4

114

J01MA12

ATC

levofloxacin; systemic

1.9

33.3

469

2662

H72.9

ICD-10 Finland

Perforation of tympanic membrane, unspecified

7.7

32.7

R74

ICPC

Upper respiratory infection acute

1.7

32.5

795

5332

RK320, ,

NOMESCO Finland

8.0

32.4

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.8

32.3

619

3871

R06AE07

ATC

cetirizine; oral

1.7

32.2

1075

7826

A02BC02

ATC

pantoprazole; systemic

1.7

31.9

1620

13126

D07AC13

ATC

mometasone; topical

1.7

30.4

711

4693

S29

ICPC

Skin symptom/complaint other

1.9

30.4

477

2798

ZXA00

NOMESCO Finland

Right side

1.8

30.1

629

4022

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

2.0

30.0

350

1856

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.6

29.9

1074

7921

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.9

29.5

459

2682

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.9

29.5

475

2806

H61.3

ICD-10 Finland

Acquired stenosis of external ear canal

50.7

29.4

XCK10

NOMESCO Finland

Photography of fundus of eye

2.3

29.4

250

1172

J01DA09

ATC

[U] cefadroxil

1.7

29.2

661

4317

AA1AD

NOMESCO Finland

CT of head and brain

1.7

29.0

624

4015

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.8

28.8

575

3620

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.8

28.8

586

3711

DBB00

NOMESCO Finland

Excision of lesion of external auditory canal

104.7

28.7

M25.5

ICD-10 Finland

Pain in joint

1.7

28.6

780

5347

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.4

28.5

214

950

R42

ICD-10 Finland

Dizziness and giddiness

1.8

28.3

531

3281

E66.8

ICD-10 Finland

Other obesity

2.6

28.2

165

651

N02BE01

ATC

paracetamol; systemic, rectal

2.0

28.2

2138

19004

P01AB01

ATC

metronidazole; oral, rectal

1.6

28.0

951

6884

ZXA05

NOMESCO Finland

Left side

1.8

27.8

575

3652

J02AC01

ATC

fluconazole; systemic

1.6

27.6

930

6711

R07.4

ICD-10 Finland

Chest pain, unspecified

1.7

27.3

663

4401

T16

ICD-10 Finland

Foreign body in ear

6.2

27.1

H02AB04

ATC

methylprednisolone; systemic

1.9

27.0

356

1966

N03AX16

ATC

[U] pregabalin

1.7

26.7

560

3565

R51.80

ICD-10 Finland

Headache

1.9

26.7

403

2325

Z01.2

ICD-10 Finland

Dental examination

1.6

26.7

1091

8227

H71

ICPC

Acute otitis media/myringitis

5.5

26.7

WX110

NOMESCO Finland

Infiltration anesthesia

1.6

26.6

1713

14371

L17

ICPC

Foot/toe symptom/complaint

1.7

26.5

684

4606

WX002

NOMESCO Finland

Sedation and analgesia

1.8

26.2

467

2836

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.6

26.2

1129

8608

M79.6

ICD-10 Finland

Pain in limb

1.6

26.0

980

7237

N02AJ06

ATC

codeine and paracetamol; systemic

1.6

25.8

1006

7487

J01AA02

ATC

doxycycline; systemic

1.7

25.4

1816

15529

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.8

25.2

492

3065

J01DC02

ATC

cefuroxime; systemic

2.6

25.0

156

635

G47.3

ICD-10 Finland

Sleep apnoea

1.7

25.0

547

3517

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.9

25.0

120

427

D07AD01

ATC

clobetasol; topical

1.8

24.9

401

2357

T90

ICPC

Diabetes non-insulin dependent

1.7

24.9

547

3520

E000001, ,

ATC

1.7

24.7

490

3065

103

Kela drug reimbursment

Diabetes, insulin-treated

1.7

24.5

612

4073

S76

ICPC

Skin infection other

2.6

24.4

147

589

UJF30

NOMESCO Finland

Ileoscopy through colon

2.1

24.3

261

1338

H02

ICPC

Hearing complaint

1.9

24.2

319

1758

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.7

24.1

541

3498

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.5

24.1

1159

8998

J20

ICD-10 Finland

Acute bronchitis

2.1

24.1

255

1300

SAA01

NOMESCO Finland

Simple examination of mouth

1.6

23.6

1710

14511

RK110, ,

NOMESCO Finland

6.5

23.5

ZXA10

NOMESCO Finland

Bilateral

1.8

23.1

427

2612

H65.4

ICD-10 Finland

Other chronic nonsuppurative otitis media

18.7

23.0

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.7

22.8

530

3454

D07CC01

ATC

betamethasone and antibiotics; topical

1.9

22.2

317

1791

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

3.0

22.2

333

XG410

NOMESCO Finland

Flow-volume spirometry

2.8

22.1

113

416

H51

ICPC

Ear, I&d/flush/aspiration

4.7

22.0

111

S18

ICPC

Laceration/cut

1.5

21.9

1031

7914

R05

ICPC

Cough

1.6

21.8

568

3806

H74.1

ICD-10 Finland

Adhesive middle ear disease

17.2

21.8

M54.5

ICD-10 Finland

Low back pain

1.6

21.7

833

6112

J01FA06

ATC

roxithromycin; oral

1.5

21.4

911

6832

L15

ICPC

Knee symptom/complaint

1.6

21.3

556

3724

A02BC05

ATC

esomeprazole; systemic

1.5

21.3

923

6949

D07AB08

ATC

desonide; topical

2.0

21.2

266

1438

Z01.8

ICD-10 Finland

Other specified special examinations

1.6

21.0

533

3542

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.8

20.9

317

1824

L40.0

ICD-10 Finland

Psoriasis vulgaris

2.7

20.9

118

458

M03BX02

ATC

tizanidine; oral

1.5

20.8

1434

11864

RK520, ,

NOMESCO Finland

8.7

20.7

R60.0

ICD-10 Finland

Localized oedema

1.9

20.5

277

1534

A02BA02

ATC

ranitidine; systemic

1.7

20.4

437

2778

ZXE00

NOMESCO Finland

One hour or less

1.5

20.3

897

6762

N07CA01

ATC

betahistine; oral

2.2

20.3

176

829

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.2

20.1

178

845

K02.1

ICD-10 Finland

Caries of dentine

1.5

20.1

1381

11379

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.0

20.1

225

1168

N06AX11

ATC

mirtazapine; oral

1.5

20.1

765

5582

D23.2

ICD-10 Finland

Benign neoplasm: Skin of ear and external auricular canal

5.4

20.0

H60.2

ICD-10 Finland

Malignant otitis externa

58.0

19.9

R02

ICPC

Shortness of breath/dyspnoea

1.8

19.9

303

1744

A06AC01

ATC

ispaghula (psylla seeds); oral

1.6

19.8

573

3928

R01BA52

ATC

pseudoephedrine, combinations; oral

1.6

19.8

673

4789

ZXD20

NOMESCO Finland

Day surgery

1.8

19.7

314

1833

SFA30

NOMESCO Finland

Three-surface restoration

1.5

19.5

964

7423

J01DC04

ATC

cefaclor; oral

4.4

19.5

114

D11

ICPC

Diarrhoea

1.9

19.4

288

1643

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.6

19.4

537

3640

UJF32

NOMESCO Finland

Coloscopy

1.6

19.3

574

3956

M03BC01

ATC

orphenadrine (citrate); systemic

1.6

19.2

536

3637

WZC00

NOMESCO Finland

Treatment plan or consultation

1.5

19.1

834

6255

L28

ICPC

Limited function/disability (L)

1.7

18.9

379

2362

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.6

18.6

586

4088

EBA00

NOMESCO Finland

Extraction of tooth

1.5

18.6

831

6253

DEB20

NOMESCO Finland

Attico-antro-mastoidectomy and tympanotomy

38.7

18.6

S02CA06

ATC

dexamethasone and antiinfectives; otic

5.4

18.5

R03BB04

ATC

tiotropium bromide; inhalant

1.9

18.5

239

1303

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.9

18.5

258

1443

D06AX01

ATC

fusidic acid; topical

1.9

18.4

229

1233

R03BA02

ATC

budesonide; inhalant

1.7

18.4

416

2676

R05FB02

ATC

cough suppressants and expectorants; systemic

1.5

18.3

818

6148

I10

ICD-10 Finland

Essential (primary) hypertension

1.5

18.2

1276

10466

A10BA02

ATC

metformin; oral

1.5

18.2

621

4410

XQ802

NOMESCO Finland

Epicutan test

2.6

18.1

110

443

S02AA03

ATC

boric acid; otic

5.3

18.0

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.8

17.9

288

1684

D01

ICPC

Abdominal pain/cramps general

1.8

17.8

282

1640

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

2.0

17.8

196

1011

R06.0

ICD-10 Finland

Dyspnoea

1.6

17.8

593

4185

XF402

NOMESCO Finland

ECG with work load test

1.9

17.8

239

1321

Z01.7

ICD-10 Finland

Laboratory examination

1.7

17.7

340

2091

H73.1

ICD-10 Finland

Chronic myringitis

67.1

17.7

Z2446

NOMESCO Finland

Social worker

2.1

17.7

173

855

SFA10

NOMESCO Finland

One-surface restoration

1.4

17.5

1264

10396

A03

ICPC

Fever

1.7

17.5

398

2561

WX722

NOMESCO Finland

PEEP

2.4

17.5

119

505

A10AE04

ATC

insulin glargine; parenteral

1.9

17.5

225

1226

A04

ICPC

Weakness/tiredness general

1.7

17.4

335

2063

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.8

17.3

303

1816

R53

ICD-10 Finland

Malaise and fatigue

1.6

17.2

530

3671

D05AX52

ATC

calcipotriol, combinations; topical

2.3

17.2

134

604

G44.2

ICD-10 Finland

Tension-type headache

1.7

17.1

319

1945

C03CA01

ATC

furosemide; systemic

1.5

17.1

590

4189

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.9

17.1

242

1360

R4120

NOMESCO Finland

Occupational therapy

2.1

17.1

162

791

N30.0

ICD-10 Finland

Acute cystitis

1.7

17.0

351

2200

DEB30

NOMESCO Finland

Radical mastoidectomy

50.4

17.0

H72.8

ICD-10 Finland

Other perforations of tympanic membrane

13.3

16.9

WX892

NOMESCO Finland

Monitored bed care

2.0

16.9

184

945

KMAK, ,

NOMESCO Finland

1.4

16.9

1172

9546

N06AB10

ATC

escitalopram; oral

1.6

16.8

466

3146

ZXD05

NOMESCO Finland

Urgent procedure

1.5

16.8

687

5054

L01

ICPC

Neck symptom/complaint

1.7

16.8

356

2248

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.9

16.8

235

1315

J45.1

ICD-10 Finland

Nonallergic asthma

2.1

16.7

173

872

E66.01

ICD-10 Finland

Obesity due to excess calories

1.9

16.7

221

1215

ZXE10

NOMESCO Finland

More than one and less than three hours

1.5

16.7

792

6003

H91.9

ICD-10 Finland

Hearing loss, unspecified

2.4

16.6

117

504

J01CE02

ATC

phenoxymethylpenicillin; oral

1.5

16.6

1571

13526

XQ800

NOMESCO Finland

Prick test

2.0

16.6

185

959

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.7

16.6

323

1994

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.0

16.5

173

876

R06AX27

ATC

desloratadine; oral

1.5

16.5

650

4742

N05BA01

ATC

diazepam; systemic, rectal

1.8

16.5

292

1754

H65.9

ICD-10 Finland

Nonsuppurative otitis media, unspecified

5.4

16.4

N05AH04

ATC

quetiapine; oral

1.6

16.2

403

2650

D07BC01

ATC

betamethasone and antiseptics; topical

1.8

16.2

274

1625

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.7

16.1

291

1758

N05BA04

ATC

oxazepam; oral

1.5

16.1

564

4013

DEB10

NOMESCO Finland

Attico-antro-mastoidectomy

24.6

16.0

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.9

16.0

214

1180

A28

ICPC

Limited function/disability NOS

1.7

16.0

337

2124

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.9

16.0

204

1108

N02BF02

ATC

pregabalin; oral

2.2

16.0

142

676

M01AB05

ATC

diclofenac; systemic, rectal

1.4

15.9

1497

12822

X59

ICD-10 Finland

Exposure to unspecified factor

1.6

15.9

425

2842

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.6

15.9

486

3353

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.4

15.8

952

7524

J31.0

ICD-10 Finland

Chronic rhinitis

1.9

15.7

203

1106

DEB25

NOMESCO Finland

Attico-antro-mastoidectomy and tympanoplasty

33.6

15.7

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.8

15.6

256

1503

K03.66

ICD-10 Finland

Tooth plaque

2.0

15.5

176

917

J34.2

ICD-10 Finland

Deviated nasal septum

2.2

15.4

134

632

N06AB04

ATC

citalopram; systemic

1.6

15.4

451

3080

TPH04

NOMESCO Finland

Cathetrisation of vein

1.6

15.3

478

3309

J45.9

ICD-10 Finland

Asthma, unspecified

1.6

15.3

417

2798

M01AE02

ATC

naproxen; oral, rectal

1.4

15.3

1299

10891

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.4

15.3

110

479

E000006, ,

ATC

2.1

15.3

154

769

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.6

15.3

398

2643

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.9

15.3

188

1008

R5110, ,

SPAT

2.1

15.2

147

722

D07AA02

ATC

hydrocortisone; topical

1.7

15.2

313

1958

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.4

15.2

895

7034

3821A

ICD-9 Finland

Suppurative and unspecified otitis media, Chronic tubotympanic suppurative otitis media

13.1

15.2

-60

ICPC

Result test/procedure

2.1

15.1

138

664

L12

ICPC

Hand/finger symptom/complaint

1.6

15.1

365

2380

U07

ICPC

Urine symptom/complaint other

2.0

15.0

166

857

H73.0

ICD-10 Finland

Acute myringitis

6.3

15.0

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.7

14.9

294

1819

38700

ICD-8 Finland

Other disease of ear and mastoid process, Cholesteatoma of ear

15.1

14.9

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.6

14.9

351

2275

J02AC02

ATC

itraconazole; systemic

1.6

14.9

387

2569

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.5

14.9

592

4315

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.8

14.8

247

1457

H62.0

ICD-10 Finland

Otitis externa in bacterial diseases classified elsewhere

31.9

14.8

C07AB07

ATC

bisoprolol; oral

1.4

14.8

1019

8222

DCD10

NOMESCO Finland

Tympanoplasty

16.6

14.8

R03DC03

ATC

montelukast; oral

1.6

14.7

376

2484

H70.0

ICD-10 Finland

Acute mastoiditis

25.2

14.7

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.5

14.7

647

4811

M54.4

ICD-10 Finland

Lumbago with sciatica

1.6

14.6

396

2652

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

2.4

14.6

414

R21

ICPC

Throat symptom/complaint

1.5

14.5

472

3296

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.1

14.4

137

669

H90.7

ICD-10 Finland

Mixed conductive and sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side

4.2

14.4

T78.4

ICD-10 Finland

Allergy, unspecified

2.3

14.4

112

505

WX290

NOMESCO Finland

Other blockage of nerve

1.4

14.4

1068

8717

E66.00

ICD-10 Finland

Metabolic syndrome

2.1

14.4

131

630

SDA03

NOMESCO Finland

Periodontal treatment

1.4

14.4

876

6910

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.8

14.3

216

1236

N06AX21

ATC

duloxetine; oral

1.7

14.3

268

1633

J01MA01

ATC

ofloxacin; systemic

1.9

14.3

185

1008

SAA02

NOMESCO Finland

Basic examination of mouth

1.4

14.3

1530

13276

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.6

14.3

342

2223

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.8

14.3

219

1260

A07AA02

ATC

nystatin; oral

2.1

14.3

130

625

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.7

14.3

288

1792

M01AE01

ATC

ibuprofen; systemic, rectal

1.6

14.1

2122

19631

L04AA06

ATC

mycophenolic acid; systemic

3.4

14.1

154

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

1.5

14.0

525

3775

J01FA01

ATC

erythromycin; systemic

1.7

13.9

307

1954

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.4

13.9

661

4977

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.6

13.9

316

2027

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.6

13.8

373

2494

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.8

13.8

226

1325

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

2.4

13.8

412

A02BC01

ATC

omeprazole; systemic

1.5

13.7

577

4243

A97

ICPC

No disease

1.6

13.7

393

2666

EMB10

NOMESCO Finland

Tonsillectomy

2.1

13.6

130

636

N06AX16

ATC

venlafaxine; oral

1.6

13.6

318

2055

X58

ICD-10 Finland

Exposure to other specified factors

1.6

13.5

319

2065

C08CA01

ATC

amlodipine; oral

1.4

13.4

769

5981

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.2

13.4

108

494

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.9

13.4

175

957

M75

ICD-10 Finland

Shoulder lesions

2.3

13.4

106

482

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.5

13.3

513

3702

H10.9

ICD-10 Finland

Conjunctivitis, unspecified

2.0

13.3

150

780

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

2.4

13.3

382

R03BA05

ATC

fluticasone; inhalant

1.5

13.3

403

2767

SAA03

NOMESCO Finland

Extended examination of mouth

1.4

13.3

886

7075

F29

ICPC

Eye symptom/complaint other

1.8

13.2

212

1236

E66

ICD-10 Finland

Obesity

2.1

13.2

126

617

4122

FHL

Tympanostomy (tympanic tube)

3.7

13.2

112

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.5

13.2

549

4025

M01AE03

ATC

ketoprofen; systemic, rectal

1.4

13.1

773

6038

H3603, E103,

ICD-10 Finland

4.5

13.1

SPF00

NOMESCO Finland

Reparation of dental prosthesis without impressions

2.8

13.1

237

K07.60

ICD-10 Finland

Snapping jaw

2.1

13.0

125

613

H04.10

ICD-10 Finland

Dry eye syndrome

1.7

13.0

243

1479

UKC02

NOMESCO Finland

Cystoscopy

1.6

13.0

329

2165

H27

ICPC

Fear of ear disease

3.8

13.0

104

M03BC51

ATC

orphenadrine, combinations; systemic

1.5

13.0

587

4370

A10AC01

ATC

insulin (human); parenteral

1.9

13.0

169

924

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.7

13.0

223

1327

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.9

12.9

155

824

B01AB05

ATC

enoxaparin; parenteral

1.4

12.9

662

5042

DE2CG

NOMESCO Finland

Acoustic channel extensive MRI examination with high intensity magnet

3.8

12.9

100

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.7

12.9

229

1375

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.1

12.9

131

657

L03

ICPC

Low back symptom/complaint

1.4

12.9

601

4500

SFA20

NOMESCO Finland

Two-surface restoration

1.4

12.9

1313

11211

H53.1

ICD-10 Finland

Subjective visual disturbances

2.0

12.9

150

790

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.6

12.8

379

2584

ZXD35

NOMESCO Finland

Usual procedure

2.5

12.8

321

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.5

12.8

424

2964

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.8

12.8

209

1226

J37.0

ICD-10 Finland

Chronic laryngitis

2.5

12.7

340

R05

ICD-10 Finland

Cough

1.5

12.7

460

3277

H25.8

ICD-10 Finland

Other senile cataract

1.8

12.7

206

1206

Z94.0

ICD-10 Finland

Kidney transplant status

4.0

12.6

A01AB09

ATC

miconazole; local oral

1.8

12.6

182

1027

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.8

12.5

209

1232

3801A

ICD-9 Finland

Disorders of external ear, Infective otitis externa[OTITIS EXTERNA ACUTA DIFFUSA]

+∞

12.5

H61.9

ICD-10 Finland

Disorder of external ear, unspecified

10.1

12.5

S21

ICPC

Skin texture symptom/complaint

1.6

12.4

299

1944

J01DA08

ATC

[U] cefaclor

1.7

12.4

256

1601

L02

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle

2.3

12.3

414

A06AD11

ATC

lactulose; oral

1.6

12.3

291

1884

L14

ICPC

Leg/thigh symptom/complaint

1.8

12.3

174

977

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.1

12.3

110

526

R52.9

ICD-10 Finland

Pain, unspecified

1.7

12.2

210

1248

3812A

ICD-9 Finland

Nonsuppurative otitis media and Eustachian tube disorders, Chronic mucoid otitis media

3.7

12.2

104

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.7

12.2

257

1615

H70.9

ICD-10 Finland

Mastoiditis, unspecified

37.7

12.2

S02

ICPC

Pruritus

2.4

12.2

341

R05FA02

ATC

opium derivatives and expectorants; systemic

1.4

12.2

850

6813

R03AK07

ATC

formoterol and budesonide; inhalant

1.5

12.2

455

3260

N05CF01

ATC

zopiclone; oral

1.4

12.1

662

5091

A01

ICPC

Pain general/multiple sites

1.8

12.1

193

1123

Z00.0

ICD-10 Finland

General medical examination

1.5

12.1

413

2903

J45

ICD-10 Finland

Asthma

1.7

12.1

221

1337

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.9

12.1

191

R03AC12

ATC

salmeterol; inhalant

2.2

12.0

458

R83

ICPC

Respiratory infection other

1.4

12.0

556

4150

H81.3

ICD-10 Finland

Other peripheral vertigo

2.7

12.0

231

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.4

12.0

369

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.5

12.0

373

2572

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.6

12.0

323

2157

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.0

11.9

122

613

H81.0

ICD-10 Finland

Ménière disease

2.8

11.9

209

H90.4

ICD-10 Finland

Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side

2.3

11.9

414

DMB00

NOMESCO Finland

Endonasal trephine of maxillary antrum

4.7

11.9

D19

ICPC

Teeth/gum symptom/complaint

1.4

11.9

609

4628

R51

ICD-10 Finland

Headache

2.0

11.9

126

642

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

5.4

11.8

N30.9

ICD-10 Finland

Cystitis, unspecified

2.0

11.8

131

678

K29.3

ICD-10 Finland

Chronic superficial gastritis

2.5

11.8

304

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

5.1

11.7

A11

ICPC

Chest pain NOS

1.8

11.7

175

999

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.9

11.7

195

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

4.6

11.6

DEB00

NOMESCO Finland

Cortical mastoidectomy

30.2

11.6

P01

ICPC

Feeling anxious/nervous/tense

1.6

11.5

265

1702

127

Kela drug reimbursment

Transplant complication

3.4

11.5

123

A08

ICPC

Swelling

2.1

11.5

112

554

H03AA01

ATC

levothyroxine sodium; systemic

1.5

11.5

481

3521

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

2.8

11.4

203

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

2.9

11.4

181

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.7

11.4

201

1204

-1, ,

NOMESCO Finland

1.4

11.4

732

5775

A02BC03

ATC

lansoprazole; oral

1.4

11.4

602

4597

L21.0

ICD-10 Finland

Seborrhoea capitis

3.8

11.3

D01AE15

ATC

terbinafine; topical

1.9

11.3

149

818

P99

ICPC

Psychological disorders other

2.4

11.3

304

TKC20

NOMESCO Finland

Catheterisation of bladder

1.9

11.3

145

790

D07XB02

ATC

triamcinolone; topical

3.4

11.2

115

RK120, ,

NOMESCO Finland

9.6

11.2

J01AA07

ATC

tetracycline; systemic

1.5

11.1

322

2182

N03AX09

ATC

lamotrigine; oral

2.1

11.1

109

540

N03AX11

ATC

topiramate; oral

2.7

11.1

229

T89

ICPC

Diabetes insulin dependent

2.2

11.1

440

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.6

11.1

257

1654

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.3

11.0

351

C10AA05

ATC

atorvastatin; oral

1.4

11.0

833

6738

M01AH05

ATC

etoricoxib; oral

1.3

11.0

1359

11822

R07.3

ICD-10 Finland

Other chest pain

1.7

11.0

218

1349

ZXC10

NOMESCO Finland

Use of laser

2.7

10.9

219

A01AB04

ATC

amphotericin B; local oral

2.2

10.9

449

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

2.2

10.9

423

N03AX12

ATC

[U] gabapentin; oral

1.5

10.9

345

2384

R03DA04

ATC

theophylline; systemic, rectal

2.0

10.9

110

551

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.6

10.9

265

1726

L13

ICPC

Hip symptom/complaint

1.5

10.9

370

2596

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.5

10.9

335

2302

N03AG01

ATC

valproic acid; systemic, rectal

1.9

10.8

133

713

A12AA04

ATC

calcium carbonate; oral

3.2

10.8

133

WZA90

NOMESCO Finland

Other medical or dental certificate

1.4

10.8

502

3739

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.2

10.8

451

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.7

10.8

194

1168

R03BA01

ATC

beclometasone; inhalant

1.6

10.8

294

1966

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.4

10.8

573

4373

DGW00

NOMESCO Finland

Dilatation of eustachian tube

10.6

10.8

L16

ICPC

Ankle symptom/complaint

1.6

10.7

248

1595

G51.0

ICD-10 Finland

Bell palsy

2.6

10.7

245

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.7

10.7

207

1272

R06AE09

ATC

levocetirizine; oral

1.5

10.6

316

2154

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.9

10.6

143

791

S97

ICPC

Chronic ulcer skin

1.9

10.6

126

669

A10BB12

ATC

glimepiride; oral

1.9

10.6

137

748

A10AB05

ATC

insulin aspart; parenteral

1.8

10.6

162

932

A11CC03

ATC

alfacalcidol; systemic

2.6

10.5

224

DFF16

NOMESCO Finland

Speech-in-noise audiometry

14.3

10.5

P29

ICPC

Psychological sympt/compl other

1.8

10.5

154

875

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.3

10.5

359

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.6

10.4

221

1390

H62.2*B44.8

ICD-10 Finland

Otitis externa in aspergillosis

+∞

10.4

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.7

10.4

186

1118

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.7

10.4

193

1172

S22

ICPC

Nail symptom/complaint

1.9

10.4

138

759

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.7

10.4

187

1126

SDA04

NOMESCO Finland

Demanding periodontal treatment

1.4

10.4

583

4485

P03

ICPC

Feeling depressed

1.7

10.4

209

1297

R03AC03

ATC

terbutaline; inhalant

1.6

10.4

293

1974

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.4

10.3

556

4247

S74

ICPC

Dermatophytosis

2.7

10.3

197

RK530, ,

NOMESCO Finland

32.7

10.3

R03AC13

ATC

formoterol; inhalant

2.0

10.3

112

576

L04AA01

ATC

[U] ciclosporin

3.5

10.3

102

A10BH05

ATC

linagliptin; oral

2.1

10.3

101

501

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.7

10.3

213

1333

L02.3

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of buttock

2.7

10.2

210

S06

ICPC

Rash localized

1.9

10.2

118

621

L29.9

ICD-10 Finland

Pruritus, unspecified

2.4

10.1

282

J01CF02

ATC

cloxacillin; systemic

2.8

10.1

182

H80.9

ICD-10 Finland

Otosclerosis, unspecified

3.9

10.1

J01CF05

ATC

flucloxacillin; systemic

1.8

10.1

140

781

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

4.2

10.1

R01AD58

ATC

fluticasone, combinations; nasal

1.4

10.1

519

3932

DAB00

NOMESCO Finland

Excision of lesion of auricle

4.0

10.0

A10AB04

ATC

insulin lispro; parenteral

2.3

10.0

321

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.9

10.0

120

639

L30.3

ICD-10 Finland

Infective dermatitis

2.2

10.0

360

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

1.9

10.0

130

712

DE2BG

NOMESCO Finland

Acoustic channel MRI examination with high intensity magnet

3.8

9.9

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.7

9.9

181

1094

Z71.9

ICD-10 Finland

Counselling, unspecified

1.8

9.9

150

860

XF404

NOMESCO Finland

Ambulatory ECG

1.7

9.9

181

1096

XKD00

NOMESCO Finland

Uroflowmetry

1.5

9.9

311

2145

WYA10

NOMESCO Finland

Emergency care or similar visit

1.8

9.9

161

944

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.4

9.8

639

5029

JN3AD

NOMESCO Finland

Abdominal CT examination

1.6

9.8

230

1483

E000003, ,

ATC

2.0

9.8

489

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.8

9.8

145

825

J01AA04

ATC

lymecycline; systemic

1.5

9.8

281

1898

H66.2

ICD-10 Finland

Chronic atticoantral suppurative otitis media

26.1

9.8

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

2.5

9.8

238

DFE00

NOMESCO Finland

Insertion of cochlear implant

10.7

9.8

M79.1

ICD-10 Finland

Myalgia

1.5

9.8

306

2108

R06.5

ICD-10 Finland

Mouth breathing

1.7

9.7

191

1178

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.9

9.7

125

681

K30

ICD-10 Finland

Functional dyspepsia

1.6

9.7

229

1479

N05CD07

ATC

temazepam; oral

1.6

9.7

223

1431

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.8

9.7

143

813

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.4

9.7

518

3947

K05.31

ICD-10 Finland

Periodontitis pronounced

1.6

9.7

226

1456

A10BH01

ATC

sitagliptin; oral

1.7

9.7

194

1203

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

1.9

9.7

117

625

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.7

9.7

192

1188

N01

ICPC

Headache

1.6

9.7

243

1594

R06AX22

ATC

ebastine; oral

1.5

9.7

360

2569

J46

ICD-10 Finland

Status asthmaticus

2.4

9.6

264

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.9

9.6

128

705

Z46.3

ICD-10 Finland

Fitting and adjustment of dental prosthetic device

3.0

9.6

143

U02

ICPC

Urinary frequency/urgency

1.5

9.6

283

1924

SXC02

NOMESCO Finland

Other oral or dental procedure, restricted

2.4

9.6

277

H3603, E113,

ICD-10 Finland

3.9

9.6

M54.8

ICD-10 Finland

Other dorsalgia

2.0

9.6

494

Z50.1

ICD-10 Finland

Other physical therapy

1.9

9.6

111

585

U71

ICPC

Cystitis/urinary infection other

1.8

9.5

134

751

TQW99

NOMESCO Finland

Other minor procedure on skin

2.0

9.5

107

557

S80.0

ICD-10 Finland

Contusion of knee

1.8

9.5

155

909

D06

ICPC

Abdominal pain localized other

1.7

9.4

181

1110

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.6

9.4

230

1498

C09CA01

ATC

losartan; oral

1.4

9.4

499

3795

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.3

9.4

299

Z2445

NOMESCO Finland

Psychologist

2.1

9.4

457

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

2.6

9.3

196

R50.9

ICD-10 Finland

Fever, unspecified

1.5

9.3

309

2153

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.6

9.3

194

1215

U13

ICPC

Bladder symptom/complaint other

2.3

9.3

300

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.7

9.3

167

1007

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.7

9.2

155

916

UJH02

NOMESCO Finland

Anoscopy

2.1

9.2

432

R31

ICD-10 Finland

Unspecified haematuria

1.6

9.2

201

1274

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.6

9.2

192

1203

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.0

9.2

508

M54

ICD-10 Finland

Dorsalgia

1.5

9.2

256

1719

R11

ICD-10 Finland

Nausea and vomiting

1.7

9.2

178

1095

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.0

9.2

101

523

EB1CA

NOMESCO Finland

Tooth X-ray additional picture

1.6

9.2

200

1268

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

2.0

9.1

482

S04

ICPC

Lump/swelling localized

1.6

9.1

214

1381

A99

ICPC

Disease/condition unspecnature/site

1.6

9.0

191

1201

N05AA02

ATC

levomepromazine; systemic

2.1

9.0

429

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

1.9

9.0

106

561

R60.9

ICD-10 Finland

Oedema, unspecified

1.9

9.0

106

561

DEA10

NOMESCO Finland

Attico-antrotomy

15.6

9.0

H62.2*B36.9

ICD-10 Finland

Otomycosis NOS

36.8

9.0

H73.8

ICD-10 Finland

Other specified disorders of tympanic membrane

36.8

9.0

H61.0

ICD-10 Finland

Perichondritis of external ear

36.8

9.0

RK290, ,

NOMESCO Finland

10.1

9.0

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

2.0

9.0

443

C05AA08

ATC

fluocortolone; rectal, topical

1.5

9.0

268

1826

N17

ICPC

Vertigo/dizziness

1.6

9.0

240

1597

EB1AA, ,

SPAT

1.7

8.9

147

864

PH2DE

NOMESCO Finland

Ultrasound examination of bloodflow in veins of lower extremity with Doppler method

2.3

8.9

280

DC1BD

NOMESCO Finland

Temporal bone extensive CT

18.7

8.9

3472A

ICD-9 Finland

Cataplexy and narcolepsy[OBSTRUKTIIVINEN UNIAPNEA]

3.3

8.9

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.9

8.9

113

614

WX320

NOMESCO Finland

Spinalanesthesy

1.4

8.9

500

3837

K11.2

ICD-10 Finland

Sialoadenitis

2.2

8.9

319

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.6

8.9

186

1168

R4190

NOMESCO Finland

Nutritional therapy

2.1

8.8

399

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.0

8.8

100

523

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.6

8.8

209

1352

C10AC01

ATC

colestyramine; oral

2.4

8.8

263

P06

ICPC

Sleep disturbance

1.5

8.8

247

1661

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.9

8.8

112

609

F31.8

ICD-10 Finland

Other bipolar affective disorders

2.7

8.8

179

XCK00

NOMESCO Finland

Perimetry

1.8

8.8

119

660

137

Kela drug reimbursment

Uraemia requiring dialysis

3.8

8.8

A98

ICPC

Health maint/preventive medicine

1.7

8.8

2313

22246

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.8

8.8

118

653

L21.8

ICD-10 Finland

Other seborrhoeic dermatitis

3.3

8.8

SFA40

NOMESCO Finland

Restoration involving the entire crown of the tooth

1.4

8.7

448

3384

R01AD12

ATC

fluticasone furoate; nasal

1.3

8.7

670

5393

SGA02

NOMESCO Finland

Opening and preparing the root canals

1.5

8.7

264

1805

R35

ICD-10 Finland

Polyuria

1.8

8.7

138

803

A29

ICPC

General symptom/complaint other

1.5

8.7

250

1690

RK420, ,

NOMESCO Finland

14.1

8.7

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

1.7

8.7

167

1025

Z02.7

ICD-10 Finland

Issue of medical certificate

1.7

8.7

146

864

R78

ICPC

Acute bronchitis/bronchiolitis

2.6

8.7

192

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

1.9

8.7

106

569

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.3

8.7

284

S10

ICPC

Boil/carbuncle

1.8

8.7

121

678

K08.80

ICD-10 Finland

Toothache NOS

1.6

8.6

187

1183

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

4.4

8.6

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.8

8.6

126

716

R01AD05

ATC

budesonide; nasal

1.7

8.6

165

1012

L02.9

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle, unspecified

2.2

8.6

317

L08

ICPC

Shoulder symptom/complaint

1.4

8.6

440

3323

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.7

8.6

171

1060

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

1.7

8.5

143

845

N05AH03

ATC

olanzapine; systemic

1.8

8.5

133

770

B35.3

ICD-10 Finland

Tinea pedis

2.0

8.5

480

L05

ICPC

Flank/axilla symptom/complaint

1.8

8.5

128

733

S20

ICPC

Corn/callosity

2.6

8.5

182

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

1.9

8.5

100

530

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.9

8.5

111

609

SPAT1039

SPAT

Otomicroscopy

2.9

8.5

137

M35.7

ICD-10 Finland

Hypermobility syndrome

3.0

8.5

121

C10AA01

ATC

simvastatin; oral

1.3

8.5

793

6559

WX110, ,

SPAT

1.8

8.5

133

772

L50.9

ICD-10 Finland

Urticaria, unspecified

2.1

8.5

399

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.6

8.4

222

1471

A10AE05

ATC

insulin detemir; parenteral

1.8

8.4

113

625

K60.1

ICD-10 Finland

Chronic anal fissure

2.4

8.4

225

N06AA09

ATC

amitriptyline; systemic

1.6

8.4

186

1184

M02AA10

ATC

ketoprofen; topical

1.5

8.4

307

2181

H68.1

ICD-10 Finland

Obstruction of Eustachian tube

2.9

8.4

138

J35.1

ICD-10 Finland

Hypertrophy of tonsils

2.7

8.4

155

ZYC01

NOMESCO Finland

Remote contact by phone

1.8

8.4

129

745

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

1.8

8.3

124

708

H93.1

ICD-10 Finland

Tinnitus

1.7

8.3

137

806

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.5

8.3

277

1931

TDA10

NOMESCO Finland

Needle biopsy of auricle or external auditory canal

8.6

8.3

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.9

8.3

499

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.5

8.3

283

1983

XG466

NOMESCO Finland

Sleep oxymetry

2.2

8.3

309

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

2.3

8.2

252

ND1CG

NOMESCO Finland

Wrist and hand extensive MRI examination with high intensity magnet

3.5

8.2

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

2.0

8.2

445

H91.2

ICD-10 Finland

Sudden idiopathic hearing loss

2.4

8.2

222

L84

ICD-10 Finland

Corns and callosities

2.1

8.2

357

J01MA06

ATC

norfloxacin; oral

1.5

8.2

251

1721

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.8

8.2

117

661

A03FA01

ATC

metoclopramide; systemic, rectal

1.4

8.2

443

3376

SGB10

NOMESCO Finland

Root filling of tooth with one root canal

1.5

8.1

248

1698

D02AE01

ATC

carbamide; topical

1.8

8.1

130

759

RK220, ,

NOMESCO Finland

4.8

8.1

-51

ICPC

I&d/flush/aspiration

3.5

8.1

J01MA14

ATC

moxifloxacin; systemic

1.6

8.1

181

1155

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.1

8.1

372

S01AA01

ATC

chloramphenicol; ophthalmic

1.9

8.1

103

561

SPF30

NOMESCO Finland

Relining of denture

2.8

8.1

141

L04

ICPC

Chest symptom/complaint

1.7

8.1

131

768

TEW99

NOMESCO Finland

Other minor procedure in surgery of teeth, jaws, mouth and pharynx

1.9

8.1

101

547

L04AX01

ATC

azathioprine; systemic

2.0

8.1

469

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

1.8

8.0

107

591

B35.6

ICD-10 Finland

Tinea inguinalis [Tinea cruris]

2.6

8.0

176

A10BJ06

ATC

semaglutide; parenteral

1.9

8.0

105

577

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.6

8.0

199

1302

T14.1

ICD-10 Finland

Open wound of unspecified body region

4.1

8.0

N03AE01

ATC

clonazepam; systemic

1.8

8.0

112

629

B05DA

ATC

Isotonic solutions

3.9

8.0

WW200

NOMESCO Finland

Immunization

2.3

8.0

256

L20.0

ICD-10 Finland

Besnier prurigo

1.7

7.9

154

948

UDM02

NOMESCO Finland

Sinoscopy

2.4

7.9

213

K59.09

ICD-10 Finland

Constipation, unspecified

1.8

7.9

124

720

C09CA06

ATC

candesartan; oral

1.4

7.9

472

3652

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.4

7.9

481

3734

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.3

7.9

653

5303

S06.0

ICD-10 Finland

Concussion

1.5

7.9

215

1438

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

2.5

7.8

184

A06AC51

ATC

ispaghula, combinations; oral

1.9

7.8

495

K04.0

ICD-10 Finland

Pulpitis

1.6

7.8

195

1277

NG1EA

NOMESCO Finland

Knee X-ray examination with wrench

3.0

7.8

116

ZXE20

NOMESCO Finland

More than three and less than five hours

1.5

7.8

267

1871

NJ3NA

NOMESCO Finland

Measurement of difference in extremity lengty with X-ray

2.9

7.8

127

A10BK01

ATC

dapagliflozin; oral

1.7

7.8

139

837

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.4

7.7

409

3101

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.5

7.7

282

2001

K29.1

ICD-10 Finland

Other acute gastritis

3.0

7.7

106

H54.7

ICD-10 Finland

Unspecified visual loss

4.2

7.7

R03AK03

ATC

[U] fenoterol and ipratropium bromide

1.9

7.7

526

J02.9

ICD-10 Finland

Acute pharyngitis, unspecified

1.8

7.7

111

628

H95.1

ICD-10 Finland

Other disorders following mastoidectomy

45.1

7.7

H76

ICPC

Foreign body in ear

3.9

7.7

XG405

NOMESCO Finland

Education on PEF monitoring

2.8

7.7

128

R51.81

ICD-10 Finland

Facial pain NOS

2.3

7.7

241

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.1

7.7

339

M70.6

ICD-10 Finland

Trochanteric bursitis

1.5

7.7

244

1685

H02BX01

ATC

methylprednisolone, combinations; systemic

1.9

7.7

520

A03FA02

ATC

cisapride; oral, rectal

1.7

7.7

141

856

4224

FHL

Endonasal anthrostomy

3.3

7.7

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

2.2

7.7

293

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.7

7.6

127

750

R55

ICD-10 Finland

Syncope and collapse

1.5

7.6

205

1366

N06AX03

ATC

mianserin; oral

1.9

7.6

529

DJD20

NOMESCO Finland

Plastic repair of septum of nose

2.0

7.6

395

A10BK03

ATC

empagliflozin; oral

1.6

7.6

193

1270

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

1.9

7.6

451

H95.0

ICD-10 Finland

Recurrent cholesteatoma of postmastoidectomy cavity

25.1

7.6

A10AB01

ATC

insulin (human); parenteral

2.1

7.6

341

TKD00

NOMESCO Finland

Dilatation of urethra

3.5

7.5

V03AE01

ATC

polystyrene sulfonate; oral

3.2

7.5

N05AX12

ATC

aripiprazole; systemic

2.0

7.5

431

CJB10

NOMESCO Finland

Laser discission of secondary cataract

1.7

7.5

139

845

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.7

7.5

123

723

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

1.8

7.5

101

560

S01GX01

ATC

cromoglicic acid; ophthalmic

1.4

7.5

406

3090

M02AA07

ATC

piroxicam; topical

1.3

7.5

694

5714

N06AB06

ATC

sertraline; oral

1.5

7.5

229

1569

N05CF02

ATC

zolpidem; oral

1.4

7.4

345

2558

IGY99

NOMESCO Finland

Other psychiatric treatment contact

2.4

7.4

201

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

3.1

7.4

R1100

NOMESCO Finland

General evaluation of the need for rehabilitation

2.9

7.4

114

K04.1

ICD-10 Finland

Necrosis of pulp

1.5

7.4

220

1497

DCA00

NOMESCO Finland

Biopsy of tympanic membrane or middle ear

80.3

7.4

A10AA01, ,

ATC

2.3

7.4

245

M89.0

ICD-10 Finland

Algoneurodystrophy

3.6

7.4

R68.2

ICD-10 Finland

Dry mouth, unspecified

6.5

7.4

Y94.0

ICD-10 Finland

Accident at home

2.6

7.4

160

K07

ICPC

Swollen ankles/oedema

1.9

7.3

463

SPAT1254

SPAT

Administration of medicine

1.4

7.3

286

2055

F51.0

ICD-10 Finland

Nonorganic insomnia

1.4

7.3

320

2348

D10

ICPC

Vomiting

1.7

7.3

120

706

J30.0

ICD-10 Finland

Vasomotor rhinitis

2.3

7.3

247

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

2.3

7.3

247

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

1.9

7.3

493

C01CA24

ATC

epinephrine; parenteral

1.7

7.3

134

814

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.7

7.3

121

715

Z49.0

ICD-10 Finland

Preparatory care for dialysis

3.5

7.3

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.6

7.3

159

1010

61610

ICD-8 Finland

Diseases of parametrium and pelvic peritoneum (female), Pelvic peritoneal adhesions, female

3.8

7.3

H3601, E103,

ICD-10 Finland

3.8

7.3

L29

ICPC

Musculoskeletal sympt/complt other

1.6

7.2

167

1074

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

2.1

7.2

300

S01

ICPC

Pain/tenderness of skin

1.9

7.2

516

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

2.8

7.2

127

TDC10

NOMESCO Finland

Removal of ventilating tube from tympanic membrane

15.8

7.2

ACC51

NOMESCO Finland

Release of median nerve

1.6

7.2

152

956

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

4.3

7.2

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.5

7.2

224

1540

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

1.9

7.2

438

69100

ICD-8 Finland

Infantile eczema and related conditions, Eczema atopicum. Prurigo Besnier. Eczema pruriginosum allergicum

2.9

7.2

111

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.6

7.2

168

1085

H83.1

ICD-10 Finland

Labyrinthine fistula

30.1

7.1

H74

ICPC

Chronic otitis media

30.1

7.1

D01AC02

ATC

miconazole; topical

1.6

7.1

151

951

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.3

7.1

486

3832

3820A

ICD-9 Finland

Suppurative and unspecified otitis media, Acute suppurative otitis media

3.3

7.1

H10

ICD-10 Finland

Conjunctivitis

1.6

7.1

147

921

T92

ICPC

Gout

2.5

7.1

169

E66.9

ICD-10 Finland

Obesity, unspecified

2.0

7.1

405

KH1AD

NOMESCO Finland

CT of urinary organs

2.0

7.1

350

C10AA04

ATC

fluvastatin; oral

1.6

7.1

155

985

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

2.4

7.1

206

H26.9

ICD-10 Finland

Cataract, unspecified

2.7

7.0

129

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.6

7.0

181

1195

DFF59

NOMESCO Finland

Other assessment of balance

3.1

7.0

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

1.9

7.0

485

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

1.9

7.0

485

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

2.3

7.0

213

K03.65

ICD-10 Finland

Deposits [accretions] on teeth betel

1.4

7.0

422

3264

J33.8

ICD-10 Finland

Other polyp of sinus

2.3

7.0

207

X57

ICD-10 Finland

Unspecified privation

2.3

7.0

207

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.1

7.0

311

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.7

7.0

132

808

QCB10

NOMESCO Finland

Major dressing of wound of skin of upper limb

2.4

7.0

201

SPAT1215

SPAT

Assessment of need for medical rehabilitation

1.9

7.0

436

K07.63

ICD-10 Finland

Pain in the jaw joint UNS

2.4

7.0

195

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

4.4

7.0

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.7

7.0

112

656

R13

ICD-10 Finland

Dysphagia

1.7

7.0

135

832

M01AB55

ATC

diclofenac, combinations; oral

1.7

6.9

123

740

O20.0

ICD-10 Finland

Threatened abortion

2.4

6.9

183

ZY010

NOMESCO Finland

Hospital outpatient

1.8

6.9

108

627

6488A

ICD-9 Finland

Other current conditions in the mother classifiable elsewhere but complicating pregnancy, childbirth and the puerperium, Abnormal glucose tolerance

2.9

6.9

108

LCA06

NOMESCO Finland

Biopsy of endometrium

1.5

6.9

215

1479

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.5

6.9

226

1571

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

1.8

6.9

517

G04AC01, ,

ATC

2.2

6.9

247

R07.0

ICD-10 Finland

Pain in throat

1.6

6.9

136

843

L50.8

ICD-10 Finland

Other urticaria

2.4

6.9

178

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.5

6.8

247

1749

H3600, E103,

ICD-10 Finland

3.2

6.8

L81

ICPC

Injury musculoskeletal NOS

2.3

6.8

203

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.6

6.8

136

844

TNX99

NOMESCO Finland

Other orthopaedic minor procedure

2.1

6.8

274

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.7

6.8

108

630

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.0

6.8

335

B34.9

ICD-10 Finland

Viral infection, unspecified

2.1

6.8

288

R81

ICPC

Pneumonia

2.0

6.8

356

Z97.8

ICD-10 Finland

Presence of other specified devices

6.1

6.8

H74.4

ICD-10 Finland

Polyp of middle ear

40.2

6.8

N05BB01

ATC

hydroxyzine; systemic

1.7

6.8

122

738

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

2.0

6.8

322

DCW99

NOMESCO Finland

Other operation on eardrum and middle ear

16.7

6.7

4145

FHL

Tympanomastoidectomy, includes possible tympanoplasty

16.7

6.7

XG460

NOMESCO Finland

Short time oxymetry

2.6

6.7

138

DM1BD

NOMESCO Finland

Extensive CT of paranasal sinuses and face area

7.2

6.7

R1220

NOMESCO Finland

Psychological examination of need and possibilities to rehabilitation

3.2

6.7

F43.1

ICD-10 Finland

Post-traumatic stress disorder

2.1

6.7

276

F31.3

ICD-10 Finland

Bipolar affective disorder, current episode mild or moderate depression

3.4

6.7

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

2.6

6.7

150

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

2.4

6.7

174

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

2.1

6.7

283

M01AB51

ATC

indometacin, combinations; oral, rectal

2.3

6.7

218

D02AX

ATC

Other emollients and protectives

2.0

6.6

324

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

2.2

6.6

244

A87

ICPC

Complication of medical treatment

3.7

6.6

K29

ICPC

Cardiovascular sympt/complt other

1.9

6.6

422

S09

ICPC

Infected finger/toe

2.0

6.6

338

K03.64

ICD-10 Finland

Dental calculus supragingival

1.3

6.6

655

5424

F03

ICPC

Eye discharge

1.6

6.6

131

812

4451

FHL

Guitar cutting

2.2

6.6

251

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

2.2

6.6

238

H92.1

ICD-10 Finland

Otorrhoea

7.8

6.6

SGA03

NOMESCO Finland

Opening and preparing the root canals, complicated

1.5

6.6

192

1302

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

3.6

6.6

W55

ICD-10 Finland

Bitten or struck by other mammals

2.0

6.6

339

L73.8

ICD-10 Finland

Other specified follicular disorders

3.2

6.6

PA6AE

NOMESCO Finland

Ulrasound examination of neck vasculature

3.4

6.6

H91.1

ICD-10 Finland

Presbycusis

1.7

6.5

107

630

DFX00

NOMESCO Finland

Connecting cochlear implant

10.0

6.5

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.3

6.5

440

3459

L20

ICPC

Joint symptom/complaint NOS

2.0

6.5

361

K10.3

ICD-10 Finland

Alveolitis of jaws

1.8

6.5

556

L72.1

ICD-10 Finland

Trichilemmal cyst

1.6

6.5

129

801

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

2.4

6.5

183

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.5

6.4

192

1309

-62

ICPC

Administrative procedure

2.1

6.4

301

N18.0

ICD-10 Finland

End-stage renal disease

3.2

6.4

Z97.2

ICD-10 Finland

Presence of dental prosthetic device (complete)(partial)

2.1

6.4

261

L71.9

ICD-10 Finland

Rosacea, unspecified

2.2

6.4

248

R32

ICD-10 Finland

Unspecified urinary incontinence

2.2

6.4

235

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

2.6

6.4

130

K04.08

ICD-10 Finland

Other specified pulpit

1.6

6.4

155

1010

R03BB01

ATC

ipratropium bromide; inhalant

1.9

6.4

385

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

2.6

6.4

136

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.6

6.4

132

828

SPAT1172

SPAT

Guidance concerning hydration

2.6

6.4

142

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.6

6.4

134

844

N05BA12

ATC

alprazolam; oral

1.5

6.3

192

1313

K59.0

ICD-10 Finland

Constipation

1.7

6.3

102

598

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.7

6.3

112

674

A10BJ02

ATC

liraglutide; parenteral

2.1

6.3

289

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

2.2

6.3

223

A10BG03

ATC

pioglitazone; oral

2.2

6.3

236

A02BA04

ATC

nizatidine; systemic

1.6

6.3

135

853

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

2.0

6.3

351

Z49.1

ICD-10 Finland

Extracorporeal dialysis

2.8

6.3

108

L40.8

ICD-10 Finland

Other psoriasis

3.6

6.3

N03AF01

ATC

carbamazepine; oral, rectal

1.8

6.3

569

N30

ICD-10 Finland

Cystitis

1.6

6.3

153

997

4141

FHL

Myringoplasty (also for reasons other than inflammation)

6.0

6.3

1450

FHL

Otomicroscopy

5.5

6.3

ICC01

NOMESCO Finland

Psychiatric treatment plan, transfer to psychiatric outpatient clinic

5.5

6.3

C09AA02

ATC

enalapril; systemic

1.4

6.3

350

2673

F39

ICD-10 Finland

Unspecified mood [affective] disorder

2.5

6.3

149

SGA04

NOMESCO Finland

Opening and preparing the root canals, extremely complicated

1.5

6.3

222

1567

M04AA01

ATC

allopurinol; systemic

1.4

6.3

233

1660

S83.6

ICD-10 Finland

Sprain and strain of other and unspecified parts of knee

1.7

6.3

105

623

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

1.8

6.3

474

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.3

6.2

371

2863

A03CA02

ATC

clidinium and psycholeptics; oral

1.7

6.2

101

594

EBA00, ,

SPAT

2.0

6.2

298

W10

ICD-10 Finland

Fall on and from stairs and steps

1.7

6.2

102

602

K03.00

ICD-10 Finland

Approximal wear

1.6

6.2

141

905

SPAT1360

SPAT

Extensive global examination

1.6

6.2

122

756

D02

ICPC

Abdominal pain epigastric

1.7

6.2

118

725

G04BD12

ATC

mirabegron; oral

1.5

6.2

208

1454

SPAT1283

SPAT

Restricted health certificate

1.4

6.2

342

2610

M01AH02

ATC

rofecoxib; oral

1.4

6.2

228

1623

A10AA02, ,

ATC

2.0

6.1

313

M54.6

ICD-10 Finland

Pain in thoracic spine

1.6

6.1

144

931

E000002, ,

ATC

1.5

6.1

214

1506

M01AX17

ATC

nimesulide; oral

1.3

6.1

451

3587

A10BJ05

ATC

dulaglutide; parenteral

2.3

6.1

194

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.7

6.1

117

719

R06AX13

ATC

loratadine; oral

1.4

6.1

298

2226

D01BA02

ATC

terbinafine; oral

1.3

6.1

495

3988

R52.2

ICD-10 Finland

Other chronic pain

1.9

6.1

405

XKD06

NOMESCO Finland

Physiologic investigation of micturition

2.0

6.1

300

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.5

6.1

200

1391

H26.4

ICD-10 Finland

After-cataract

1.5

6.1

161

1070

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.0

6.1

328

R2110

NOMESCO Finland

Giving the first information

1.6

6.1

131

830

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.2

6.1

1042

9174

DHB50

NOMESCO Finland

Turbinoplasty

2.0

6.1

287

D05AX02

ATC

calcipotriol; topical

1.9

6.1

385

G63.2*E10.4

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic polyneuropathy

8.6

6.1

H01.0

ICD-10 Finland

Blepharitis

1.6

6.0

126

792

NK1XE

NOMESCO Finland

Other ultrasound examinnation of muscle or tendon

3.1

6.0

H54.2

ICD-10 Finland

Moderate visual impairment, binocular

3.6

6.0

4939X

ICD-9 Finland

Asthma, unspecified[ASTHMA BRONCHIALE NUD]

2.7

6.0

111

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

1.8

6.0

532

C05AA01

ATC

hydrocortisone; rectal, topical

1.7

6.0

562

Z49.2

ICD-10 Finland

Other dialysis

3.5

6.0

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3007853) Bacteria identified in Skin by Aerobe culture

821

2222

5.06

289.66

2.6

1.7

—

(3000494) Fungus identified in Specimen by Culture

616

2236

3.35

132.27

2.0

1.4

—

(3042936) Bacteria identified in Isolate by Culture

554

2767

2.30

58.45

2.2

2.0

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1151

7671

1.95

55.14

2.3

1.9

95.80

95.35

pmol/l

0.11

602

4080

(3018010) Neutrophils/100 leukocytes in Blood

1328

9510

1.87

48.84

6.9

5.8

57.02

56.90

0.14

1231

8968

(3022096) Basophils/100 leukocytes in Blood

1274

9035

1.86

48.03

7.2

6.0

0.70

0.67

1.08

1174

8473

(3006504) Eosinophils/100 leukocytes in Blood

1300

9322

1.84

46.84

7.1

5.9

2.90

2.82

0.62

1203

8759

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

454

2270

2.23

46.75

4.8

4.3

31.87

32.29

0.34

322

1591

(3019069) Monocytes/100 leukocytes in Blood

1303

9372

1.84

46.27

7.5

6.2

8.45

8.54

0.49

1203

8818

(3002030) Lymphocytes/100 leukocytes in Blood

1331

9644

1.83

46.06

7.3

6.0

28.34

28.28

0.07

1234

9104

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1200

8518

1.80

43.54

6.9

6.1

1.22

1.21

mmol/l

3.44

1104

7788

(3033658) Prothrombin time (PT) actual/Normal

780

4935

1.85

40.69

4.1

3.9

92.22

90.74

0.84

760

4798

(3013115) Eosinophils [#/volume] in Blood

1373

10291

1.76

39.99

7.1

6.0

0.20

0.19

e9/l

1.80

1198

9080

(3006315) Basophils [#/volume] in Blood

1333

9948

1.75

39.03

6.9

5.8

0.04

e9/l

1.69

1134

8658

(3019198) Lymphocytes [#/volume] in Blood

1361

10223

1.75

38.88

6.9

5.8

2.03

1.96

e9/l

0.37

1205

9110

(3001604) Monocytes [#/volume] in Blood

1329

9927

1.74

38.63

6.9

5.8

0.59

0.57

e9/l

2.09

1137

8643

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

533

3029

1.97

38.25

3.0

2.9

3.40

2.43

e6/l

1.07

305

1649

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1835

15107

1.86

37.54

8.3

7.3

76.85

77.74

u/l

0.40

1748

14260

(3013707) Erythrocyte sedimentation rate by Westergren method

1785

14621

1.82

36.49

4.8

4.0

12.40

11.68

mm/h

1.37

1655

13568

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1259

9415

1.70

35.09

8.1

6.8

1.22

1.21

mmol/l

1.75

1140

8022

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1326

10101

1.68

34.06

5.7

6.1

10.46

11.37

umol/l

3.59

1258

9588

(3037467) Urinalysis macro (dipstick) panel - Urine

1671

13584

1.73

33.23

5.3

4.1

—

(40760892) CBC W Ordered Manual Differential panel - Blood

1238

9321

1.67

32.76

7.1

6.3

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

1461

11483

1.68

32.71

5.4

4.8

6.88

6.69

mmol/l

2.23

1381

10704

(3013650) Neutrophils [#/volume] in Blood by Automated count

1466

11562

1.67

32.11

9.5

8.8

4.14

4.09

e9/l

0.33

1246

10134

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

240

1068

2.38

31.88

1.7

1.6

—

(3019225) pH of Specimen

353

1839

2.07

31.82

5.3

4.2

—

(40768804) Tissue Pathology biopsy report

1085

7960

1.65

31.28

2.3

2.1

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

345

1808

2.06

30.53

2.6

2.3

28.67

66.34

u/l

0.81

286

1542

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

720

4768

1.72

30.44

2.5

2.4

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

530

3224

1.82

29.99

2.9

2.7

0.93

1.13

e6/l

0.55

301

1833

(3044640) Blood type and Crossmatch panel - Blood

883

6216

1.66

29.44

2.5

2.4

—

(40758558) Short blood count panel - Blood

746

5044

1.69

28.93

6.8

6.5

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2226

20047

2.24

28.85

18.4

13.5

22.22

23.18

mg/l

0.70

1886

15778

(3031040) Bacteria [#/volume] in Urine by Automated count

1583

12915

1.64

28.67

5.2

4.2

2977.88

1432.02

e6/l

—

181

(3018095) Leukocytes [#/volume] in Urine

949

6843

1.63

28.53

4.3

3.6

100.06

105.91

e6/l

0.08

649

4795

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2088

18397

1.93

28.49

5.6

4.6

1.87

2.07

mu/l

0.96

1902

16978

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

490

2995

1.80

26.97

2.0

1.8

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

181

768

2.47

26.62

5.1

4.2

24.66

24.88

mmol/l

0.45

168

725

(3022217) INR in Platelet poor plasma by Coagulation assay

1143

8736

1.58

26.25

15.0

14.2

1.19

1.25

inr

1.19

219

2635

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2102

18741

1.87

25.09

16.5

12.4

83.63

83.15

ml/min/173m2

0.43

1777

15444

(3007164) IgA [Mass/volume] in Serum or Plasma

601

3970

1.68

24.81

1.5

2.46

2.39

g/l

0.29

324

2475

(3024561) Albumin [Mass/volume] in Serum or Plasma

1078

8227

1.56

24.28

5.6

4.8

35.72

35.70

g/l

0.05

998

7654

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

562

3666

1.69

24.25

4.0

3.6

472.45

718.18

ng/l

0.32

406

2726

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1602

13372

1.57

23.97

3.6

3.1

50.84

47.24

u/l

0.72

1498

12532

(3019309) Folate [Moles/volume] in Red Blood Cells

522

3360

1.70

23.59

1.8

1.7

974.70

1162.89

nmol/l

5.44

372

2584

(3019550) Sodium [Moles/volume] in Serum or Plasma

2232

20389

2.09

23.55

20.4

15.3

139.52

139.67

mmol/l

2.18

2182

19876

(3023368) Bacteria identified in Blood by Culture

725

5081

1.61

23.44

4.5

4.4

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

2235

20457

2.08

22.97

20.7

15.4

3.96

mmol/l

0.34

2179

19910

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

793

5703

1.58

22.86

2.1

164.50

231.30

u/l

1.78

754

5367

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

371

2202

1.81

22.16

2.4

2.7

8.92

8.11

umol/l

0.21

325

1917

(3021960) Folate [Moles/volume] in Serum or Plasma

626

4301

1.61

21.68

1.6

1.5

20.02

20.35

nmol/l

0.23

540

3709

(3002582) Erythrocytes [#/volume] in Urine

799

5821

1.55

21.46

3.6

3.2

39.10

97.26

e6/l

2.35

619

4467

(40768797) Stomach Pathology biopsy report

429

2696

1.72

20.92

1.3

1.2

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1034

7995

1.51

20.90

2.6

2.2

75.49

76.45

nmol/l

0.46

929

7230

(3022313) Gas panel - Capillary blood

188

905

2.17

20.54

5.1

4.0

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

628

4371

1.59

20.41

1.8

1.12

1.13

mg/l

0.03

475

3305

(3037121) Protein [Mass/volume] in Urine

153

678

2.34

20.40

3.9

3.2

0.26

0.29

g/l

0.19

269

(3037522) Nuclear Ab [Titer] in Serum

426

2690

1.71

20.37

1.4

1.3

484.04

524.87

titre

0.22

550

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1115

8811

1.49

19.96

3.2

2.8

108.37

120.03

ug/l

1.22

1031

8200

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

873

6595

1.50

19.32

3.3

3.1

32.96

32.99

u/l

0.00

824

6269

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

231

1228

1.97

19.30

5.0

3.9

5.17

5.15

kpa

0.16

219

1176

(3030467) Casts [#/volume] in Urine by Automated count

730

5312

1.53

19.29

3.6

3.0

0.30

0.44

e6/l

1.93

547

4034

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

163

763

2.22

19.09

2.1

1.9

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

706

5115

1.53

18.97

2.9

3.0

1404.48

1315.22

ng/l

0.20

581

4346

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

150

680

2.28

18.97

2.0

1.8

—

(36304419) Bacteria [Presence] in Urine

714

5188

1.53

18.92

3.5

3.0

—

(3009508) Creatinine [Moles/volume] in Urine

811

6061

1.51

18.79

3.9

3.2

7.44

7.69

mmol/l

0.76

665

5189

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1764

15395

1.52

18.60

4.5

3.9

14.62

14.72

pmol/l

0.89

1592

14099

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

219

1164

1.97

18.29

5.0

3.9

1.11

1.79

mmol/l

2.22

173

865

(3026493) Urate [Moles/volume] in Serum or Plasma

696

5070

1.52

18.08

2.8

2.6

1296.93

4759.58

umol/l

3.80

608

4464

(3009343) pH of Capillary blood

225

1213

1.94

18.02

5.0

3.9

7.43

7.41

1.67

141

(36660697) Celiac disease serology panel - Serum

271

1570

1.82

17.34

1.2

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

673

4913

1.51

17.14

2.5

2.2

2.93

2.90

mg/l

0.08

552

4186

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

501

3434

1.58

16.98

1.3

24.52

32.05

iu/ml

0.70

140

1113

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

629

4535

1.52

16.97

1.4

1.3

1.53

1.55

u/ml

0.02

104

1221

(3052851) Hemolysis interference index of Serum or Plasma

128

572

2.31

16.75

3.1

3.3

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1994

18035

1.57

16.37

7.1

5.4

41.05

39.51

mmol/mol

8.64

1825

16777

(3014111) Lactate [Moles/volume] in Serum or Plasma

277

1647

1.77

16.21

7.7

1.29

1.38

mmol/l

1.05

270

1601

(3012516) Albumin [Mass/volume] in Urine

739

5577

1.47

15.70

4.0

3.3

285.95

344.40

mg/l

0.16

500

3635

(3000991) Gas panel - Venous blood

268

1595

1.76

15.61

9.4

8.8

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1534

13241

1.43

15.31

3.4

3.1

—

(3013512) EKG study

719

5442

1.46

14.89

4.2

3.7

—

(3003327) Ova and parasites identified in Stool by Light microscopy

133

641

2.14

14.50

1.7

—

(1761868) Lipid panel - Serum or Plasma

539

7243

0.67

14.40

2.7

—

(3020682) Albumin/Creatinine [Ratio] in Urine

763

5873

1.43

14.33

4.7

3.8

9.86

8.74

mg/mmol

0.28

504

3778

(3018418) pH of Serum or Plasma

727

5548

1.44

14.30

4.4

3.9

7.39

7.40

1.42

1068

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2262

21282

1.84

14.18

12.7

10.0

27.63

26.43

u/l

1.76

2190

20578

(3048689) Calprotectin [Mass/mass] in Stool

371

2473

1.59

13.94

2.7

2.4

149.12

126.73

ug/g

0.51

283

1987

(40761511) CBC panel - Blood by Automated count

2233

20948

1.76

13.88

15.7

12.5

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

179

987

1.88

13.36

10.0

10.5

24.19

24.30

mmol/l

0.18

174

961

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

776

6076

1.41

12.96

2.8

2.5

54.24

58.89

u/l

2.15

716

5628

(3022948) Iron [Moles/volume] in Serum or Plasma

427

2985

1.52

12.91

2.8

2.5

13.24

13.43

umol/l

0.21

394

2784

(3004789) Transferrin [Mass/volume] in Serum or Plasma

399

2749

1.54

12.90

2.9

2.4

2.30

2.34

g/l

0.61

367

2545

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

316

2067

1.61

12.80

1.9

1.7

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

819

6485

1.40

12.76

3.5

3.3

2.35

mmol/l

0.04

699

5757

(4146454) Self-monitoring of blood glucose

191

2.98

12.70

3.2

2.5

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

371

2525

1.55

12.66

7.8

5.9

1.04

1.05

mmol/l

0.28

336

2348

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

230

2.79

12.63

2.3

19.75

25.09

mg/l

0.46

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2071

19160

1.53

12.57

5.4

4.3

6.10

5.90

mmol/l

6.56

1899

17567

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

375

2565

1.55

12.51

3.0

2.5

22.55

23.41

0.63

329

2194

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

282

1810

1.63

12.32

2.2

2.3

0.22

0.21

g/l

0.67

259

1687

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

227

1385

1.70

12.04

4.9

4.0

98.51

88.82

ng/l

0.59

194

1220

(3007461) Platelets [#/volume] in Blood

2341

22404

2.07

12.00

26.7

19.7

253.51

252.02

e9/l

0.52

2285

21849

(3024731) MCV [Entitic volume]

2342

22418

2.07

11.98

26.6

19.6

90.87

90.84

0.11

2313

22116

(3035941) MCH [Entitic mass]

2342

22419

2.07

11.96

26.5

19.6

30.24

30.28

0.54

2314

22114

(3010813) Leukocytes [#/volume] in Blood

2342

22420

2.07

11.95

26.7

19.7

7.01

6.74

e9/l

3.61

2283

21803

(3026361) Erythrocytes [#/volume] in Blood

2342

22421

2.07

11.93

26.6

19.7

4.50

e12/l

0.12

2281

21801

(3026008) Bacteria identified in Urine by Culture

731

5736

1.39

11.83

3.2

2.9

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

884

7158

1.37

11.78

3.7

3.5

44.20

54.60

ng/l

0.32

575

4711

(3000963) Hemoglobin [Mass/volume] in Blood

2342

22430

2.06

11.77

26.8

19.8

134.95

135.63

g/l

1.45

2314

22123

(3012095) Magnesium [Moles/volume] in Serum or Plasma

435

3108

1.49

11.75

3.3

3.4

0.81

0.82

mmol/l

2.10

399

2935

(3009542) Hematocrit [Volume Fraction] of Blood

2339

22393

2.04

11.74

26.9

19.8

40.28

40.45

0.29

2248

21011

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

137

727

1.94

11.50

1.7

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

222

1365

1.69

11.44

2.4

14.77

24.03

au/ml

1.24

113

(3022145) Colonoscopy Study observation

320

2153

1.56

11.44

1.3

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

583

4422

1.42

11.43

3.4

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

454

3291

1.47

11.36

1.3

1.2

18.08

11.30

u/ml

0.25

143

1313

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

220

1358

1.68

11.17

1.8

1.6

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

360

2498

1.52

11.16

1.7

1.53

1.46

0.88

315

2204

(3017143) Hepatitis C virus Ab [Presence] in Serum

345

2373

1.53

11.15

1.9

1.6

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

310

2085

1.56

11.09

1.9

1.8

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1112

9402

1.34

10.88

2.8

2.6

—

(4200892) Spirometry reversibility

216

1339

1.67

10.79

1.4

—

(3005322) IgE [Units/volume] in Serum or Plasma

208

1283

1.68

10.59

1.4

1.3

524.98

201.90

u/ml

0.73

195

1191

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

405

2.19

10.42

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

405

2.19

10.42

1.3

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

107

548

2.00

9.98

1.5

1.4

287.55

286.26

ug/g

0.02

317

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

116

614

1.93

9.85

1.4

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

308

2128

1.51

9.69

3.9

4.3

231.32

246.90

u/l

1.55

292

2017

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

411

2.13

9.67

1.6

1.4

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

187

2.71

9.65

1.3

1.2

47.64

60.49

u/l

1.27

172

(40761536) Microorganisms panel - Urine sediment

1730

0.50

9.61

4.7

3.6

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

121

656

1.89

9.57

2.2

2.4

2.79

2.92

g/l

0.84

108

597

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

126

697

1.85

9.36

2.2

2.4

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

126

697

1.85

9.36

2.2

2.4

7.33

7.32

g/l

0.03

112

638

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

232

2.49

9.30

1.7

1.5

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

232

2.49

9.30

1.7

1.5

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

233

2.48

9.22

1.7

1.5

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

230

1506

1.58

9.21

1.6

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

234

2.47

9.14

1.7

1.5

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

235

2.46

9.06

1.7

1.5

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

237

2.44

8.90

1.7

1.5

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

124

697

1.82

8.77

2.2

2.4

3.55

3.66

g/l

0.54

112

638

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

110

598

1.88

8.65

2.1

2.5

0.12

1.08

g/l

6.40

524

(3005719) IgG [Mass/volume] in Serum or Plasma

229

1523

1.56

8.57

2.3

2.7

10.37

10.53

g/l

0.25

209

1398

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

175

2.60

8.10

1.3

1.54

1.43

nmol/l

0.24

159

(3000850) Epithelial cells [#/volume] in Urine

517

4042

1.35

8.10

2.7

2.5

5.99

5.98

e6/l

0.01

448

3609

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

525

1.90

8.08

2.2

2.3

0.01

0.02

g/l

0.54

484

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

101

549

1.88

7.97

2.1

2.2

39.30

37.74

g/l

2.02

490

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2110

19959

1.42

7.95

5.5

4.7

2.74

2.77

mmol/l

0.78

1932

18537

(3004616) Nuclear Ab [Presence] in Serum

232

2.36

7.89

1.4

1.2

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

101

551

1.87

7.89

1.3

1.2

4.00

52.33

u/ml

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

172

1091

1.62

7.88

1.6

1.5

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

405

2.01

7.78

1.2

1.53

4.73

u/ml

—

(3029937) Albumin [Presence] in Urine by Test strip

402

5203

0.73

7.64

4.2

3.8

0.00

estimate

1.08

124

1808

(3020779) Urea [Moles/volume] in Serum or Plasma

245

1695

1.50

7.63

10.0

7.4

10.73

9.56

mmol/l

1.48

223

1616

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

113

647

1.78

7.56

2.3

2.4

9.79

10.16

g/l

0.52

101

585

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

615

7476

0.76

7.55

3.8

3.6

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

638

5190

1.31

7.53

1.7

1.49

1.38

mmol/l

2.20

574

4373

(3017732) Neutrophils [#/volume] in Blood

203

1357

1.54

7.44

2.9

3.0

4.24

5.36

e9/l

1.30

152

1134

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

447

3462

1.36

7.38

3.4

3.0

2.44

mmol/l

0.18

396

3033

(3045414) Leukocytes [Presence] in Urine

144

889

1.66

7.35

2.2

1.8

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

513

1.87

7.35

1.3

1.2

21.31

9.85

u/ml

0.42

(3026782) Osmolality of Urine

488

3844

1.34

7.19

3.1

2.8

541.35

544.09

mosm/kgh2o

0.10

405

3301

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

496

1.87

7.15

2.3

0.00

g/l

-0.00

456

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2074

19637

1.37

7.10

5.0

4.2

4.58

4.66

mmol/l

3.12

1904

18357

(3009466) Valproate [Moles/volume] in Serum or Plasma

296

2.12

7.08

5.4

5.7

346.09

362.91

umol/l

0.45

259

(3028707) Methadone [Presence] in Urine by Screen method

350

2.03

7.07

1.7

2.6

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

506

1.85

7.04

1.3

1.2

5.82

2.52

u/ml

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1998

18820

1.34

7.00

4.4

3.8

1.38

1.28

mmol/l

6.74

1814

17373

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

3.31

6.96

1.6

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

3.31

6.96

1.6

1.4

—

(3041096) Erythrocytes [Presence] in Urine by Automated

424

5374

0.74

6.92

3.3

3.2

—

(3002619) Bacteria identified in Specimen by Culture

5.46

6.91

1.6

1.1

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

119

2.80

6.90

1.5

1.6

8.28

5.46

u/l

0.39

103

(3018677) aPTT in Platelet poor plasma by Coagulation assay

387

2961

1.36

6.88

2.0

2.1

30.51

29.80

0.94

375

2870

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1548

0.56

6.85

5.6

3.6

1.23

mmol/l

0.00

1334

(3013139) Helicobacter pylori Ag [Presence] in Stool

194

1309

1.52

6.82

1.2

—

(3051611) Lipemic interference index of Serum or Plasma

191

2.38

6.80

3.7

3.3

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

301

2.09

6.79

1.5

1.6

0.69

0.80

g/l

0.33

238

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

492

1.84

6.71

2.3

0.00

g/l

-0.00

455

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

481

3820

1.32

6.65

1.7

1.5

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

100

575

1.77

6.63

1.9

1.7

0.22

0.24

g/l

1.16

547

(3024928) Oxygen saturation in Venous blood

394

1.93

6.61

4.1

3.5

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

305

2261

1.40

6.57

2.3

1.9

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

487

3881

1.32

6.57

2.1

1.9

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

131

814

1.64

6.55

1.8

1.4

9.44

22.45

u/ml

—

(40768443) Skin Pathology biopsy report

131

814

1.64

6.55

1.3

1.2

—

(3027945) Reticulocytes/100 erythrocytes in Blood

288

2117

1.41

6.51

2.6

2.7

1.81

1.79

0.14

245

1886

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

332

2501

1.38

6.49

2.4

2.1

—

(3023520) Reticulocytes [#/volume] in Blood

222

1558

1.47

6.45

2.5

2.7

70.07

71.04

e9/l

0.15

164

1174

(3026389) Candida sp identified in Specimen by Organism specific culture

241

2.18

6.42

1.3

1.4

—

(40768446) Kidney Pathology biopsy report

3.31

6.41

1.7

1.6

—

(3000492) Spirometry study

274

2003

1.41

6.39

1.6

1.4

—

(3002032) Base excess in Venous blood by calculation

246

1764

1.44

6.39

4.7

4.0

1.46

1.92

mmol/l

1.36

217

1445

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

2.96

6.27

1.7

1.4

—

(3020630) Protein [Mass/volume] in Serum or Plasma

216

1517

1.46

6.26

2.7

67.20

66.39

g/l

0.87

191

1396

(3021447) Carbon dioxide [Partial pressure] in Venous blood

246

1773

1.43

6.21

4.7

3.9

5.91

5.86

kpa

0.33

240

1718

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2055

19515

1.33

6.21

5.0

4.2

1.39

1.46

mmol/l

11.10

1878

18128

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

2.92

6.16

1.7

1.4

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

120

742

1.65

6.14

1.4

1.2

0.31

0.94

u/ml

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

132

836

1.61

6.14

2.0

1.9

1.65

1.51

g/l

1.01

118

730

(3028026) IgM [Mass/volume] in Serum or Plasma

178

1207

1.51

6.13

1.5

1.8

1.30

1.39

g/l

0.23

159

1111

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

2.85

6.10

1.5

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

2.85

6.10

1.5

1.9

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

4.12

6.08

1.0

1.1

—

(1002224) Polysomnography panel

133

846

1.61

6.08

1.0

1.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

3.10

6.04

1.5

2.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

3.10

6.04

1.6

2.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

3.10

6.04

1.5

2.1

—

(3021589) Normoblasts [#/volume] in Blood

1014

8913

1.24

5.98

9.4

9.1

0.00

e9/l

1.13

786

7290

(3007566) Smooth muscle Ab [Titer] in Serum

535

1.75

5.91

1.3

1.2

78.00

87.00

titre

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

3.41

5.86

1.2

1.1

—

(3026250) Tacrolimus [Mass/volume] in Blood

3.02

5.80

38.5

31.7

7.33

7.26

ug/l

0.06

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

308

1.97

5.70

1.5

1.3

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

409

1.83

5.64

1.3

1.2

8.31

46.56

u/ml

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

405

3210

1.31

5.62

1.8

1.6

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

189

2.24

5.61

3.4

3.5

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

205

1457

1.44

5.60

2.3

1.9

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

146

2.42

5.55

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

146

2.42

5.55

1.2

1.1

—

(3020491) Glucose [Moles/volume] in Blood

134

2.48

5.53

1.9

2.0

7.06

6.88

mmol/l

0.12

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

147

2.40

5.47

1.2

1.1

—

(3011288) Drugs identified in Urine by Screen method

548

1.71

5.45

1.7

2.8

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

3.24

5.45

1.2

1.1

—

(3002385) Erythrocyte distribution width [Ratio]

1862

17543

1.26

5.40

21.3

15.9

18.07

14.79

0.72

1839

17215

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

144

964

1.52

5.30

2.3

—

(3005570) Glucose [Moles/volume] in Urine

214

2.12

5.27

1.9

2.1

—

(3004588) Protein electrophoresis panel - Serum or Plasma

177

1241

1.46

5.20

2.1

2.4

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

145

2.36

5.16

1.2

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

145

2.36

5.16

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

145

2.36

5.16

1.2

1.1

—

(3036180) Methadone [Presence] in Urine

2.81

5.14

1.3

1.9

—

(3025941) Bacteria identified in Stool by Culture

162

1120

1.48

5.12

1.3

1.2

—

(3049717) Cytology report of Urine Cyto stain

113

726

1.58

5.01

2.7

2.6

—

(3036489) Thrombin time

117

765

1.56

4.82

1.8

2.3

21.13

21.29

0.17

107

675

(3014765) Yersinia sp identified in Stool by Organism specific culture

591

1.63

4.81

1.2

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

257

1.97

4.79

2.7

1.7

1520.00

1506.67

titre

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

2.75

4.77

1.6

3.1

126.89

123.88

umol/l

—

(3045424) Erythrocytes [Presence] in Urine

332

1.83

4.62

1.8

1.5

—

(42529406) Shigella sp [Presence] in Stool by Culture

598

1.61

4.61

1.2

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

179

2.14

4.60

3.1

4.0

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

254

1.95

4.60

1.4

1.5

—

(3024354) Oxygen [Partial pressure] in Venous blood

198

1451

1.40

4.59

3.7

3.3

4.82

4.58

kpa

0.88

191

1401

(3002256) Pathology report gross observation

320

2529

1.31

4.52

1.3

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

162

1152

1.44

4.45

2.2

1.8

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

588

1.60

4.44

1.2

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

197

1452

1.39

4.42

2.2

11.89

12.61

nmol/l

0.49

161

1303

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

399

1.72

4.32

1.3

1.2

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

394

1.72

4.23

4.9

5.3

416.67

730.73

iu/ml

—

(3022689) Creatine [Moles/volume] in Urine

3.15

4.20

1.6

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

574

1.59

4.17

1.1

1.2

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

241

1854

1.33

4.13

2.4

2.1

388.09

374.02

nmol/l

0.47

220

1711

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

568

1.59

4.11

1.4

1.3

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

123

843

1.48

4.11

1.7

2.0

38.01

39.09

u/l

0.26

107

752

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

308

1.80

4.11

1.2

1.1

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

168

2.10

4.07

3.1

3.3

60.00

54.07

0.79

149

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.87

4.06

1.1

1.3

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

8.02

4.06

7.8

3.8

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

634

1.55

4.05

3.0

3.2

0.30

0.34

u/ml

0.86

354

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

162

2.11

4.04

1.2

1.3

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

2.61

3.97

1.1

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

510

1.61

3.97

1.5

1.3

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

106

2.37

3.90

1.2

14.75

15.80

u/l

0.08

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

585

1.56

3.87

2.0

2.7

186.02

185.08

0.04

560

(3004809) Band form neutrophils/100 leukocytes in Blood

286

1.80

3.82

3.6

3.2

1.55

1.38

0.10

260

(3035637) Corticotropin [Mass/volume] in Plasma

244

1.86

3.75

1.4

1.5

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

4.60

3.74

1.3

1.4

47.45

48.21

umol/l

0.02

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

2.41

3.72

9.4

5.8

41.60

39.48

u/ml

—

(3014051) Protein [Presence] in Urine by Test strip

511

1.58

3.72

2.7

2.2

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

615

1.53

3.71

1.6

1.8

—

(3015736) pH of Urine

869

7782

1.18

3.71

3.3

3.2

5.95

5.85

0.44

611

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

608

1.53

3.69

2.4

2.7

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

201

1534

1.34

3.65

3.3

2.9

176.70

191.63

ng/l

0.27

176

1391

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

143

1035

1.41

3.62

10.8

10.9

—

(3044927) Protein electrophoresis panel - Urine

185

1.96

3.53

1.2

—

(21494755) Public health laboratory ask at order entry panel

150

2015

0.73

3.52

1.3

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

4.25

3.50

1.2

1.0

—

(4035726) Immunohistochemistry procedure

214

1664

1.31

3.43

1.4

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

147

2.05

3.36

1.3

1.2

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

185

1416

1.33

3.32

1.2

166.82

161.81

iu/ml

0.05

548

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

163

1226

1.35

3.29

2.5

3.3

4.43

4.52

pmol/l

0.59

139

1095

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

2.30

3.26

1.0

—

(3035320) C reactive protein [Mass/volume] in Body fluid

136

2.07

3.22

3.1

2.2

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

235

1867

1.29

3.22

3.2

4.2

15.33

21.17

ug/l

0.22

188

1517

(3003888) Timothy IgE Ab [Units/volume] in Serum

364

1.64

3.20

1.0

1.1

4.33

4.56

u/ml

0.03

195

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

2.96

3.13

1.0

1.2

115.83

96.36

ug/l

—

(21494815) CD4 cells/100 lymphocytes in Specimen

152

1.99

3.10

1.7

2.2

40.49

39.96

0.06

152

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

3.68

3.08

4.1

6.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

4.01

3.08

1.1

1.5

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

553

1.50

3.05

1.2

1.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

182

1.88

3.01

3.8

4.7

91.72

62.27

u/ml

—

(3023199) Leukocytes [#/volume] in Pleural fluid

211

1.81

3.00

1.4

2544.86

1701.60

e6/l

0.43

147

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

394

0.45

2.97

1.4

1.5

—

(3003396) Base excess in Arterial blood by calculation

263

2142

1.26

2.95

8.6

8.1

0.56

1.04

mmol/l

1.07

216

1692

(3023511) Choriogonadotropin [Units/volume] in Urine

438

1.54

2.89

1.5

1.3

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

359

1.60

2.88

1.2

—

372.50

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

544

1.49

2.87

5.2

4.0

1.60

1.50

mg/l

0.49

504

(40763480) Human metapneumovirus Ag [Presence] in Specimen

6.68

2.87

1.0

1.3

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

102

2.17

2.87

2.0

2.2

39.63

136.16

ug/min

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

594

1.46

2.86

2.2

2.8

3.90

3.59

g/l

0.90

557

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

263

2151

1.25

2.85

8.6

8.1

5.17

5.11

kpa

0.53

253

2049

(3027801) Oxygen [Partial pressure] in Arterial blood

263

2152

1.25

2.84

8.5

8.0

11.57

12.37

kpa

1.79

254

2052

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

546

1.48

2.83

1.1

24.29

4.47

u/ml

0.53

(3027923) C peptide [Moles/volume] in Serum or Plasma

116

2.08

2.82

2.0

1.4

1.40

1.26

nmol/l

0.22

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

322

1.63

2.82

1.3

1.2

5.28

5.16

u/ml

0.02

141

(3044290) Cell count panel - Cerebral spinal fluid

425

1.54

2.81

1.1

1.5

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

307

1.64

2.80

1.3

1.2

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

523

1.49

2.79

1.7

2.2

11.77

11.04

mg/l

0.39

480

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

2.55

2.78

1.0

1.1

—

(3029075) Extractable nuclear Ab panel - Serum

2.55

2.78

1.0

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

111

2.08

2.73

1.6

1.5

—

(3023419) Bacteria identified in Sputum by Culture

294

1.65

2.72

2.4

2.7

—

(3000475) Leukocytes [#/volume] in Synovial fluid

463

1.50

2.67

1.4

1.7

11916.53

13945.92

e6/l

0.13

342

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

695

6249

1.16

2.66

5.1

4.8

2.08

3.04

ug/l

2.72

611

5610

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

2.47

2.62

1.4

3.0

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

2.55

2.61

1.1

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

140

1072

1.32

2.57

1.1

1.0

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

114

2.03

2.56

1.2

2.0

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

284

1.63

2.55

1.5

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

333

1.57

2.49

1.3

1.2

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

193

1549

1.27

2.49

2.1

2.4

6.19

7.53

ug/l

0.66

155

1396

(3038026) Centromere Ab [Units/volume] in Serum

158

1.85

2.48

1.1

—

72.50

—

(40768806) Pleura Pathology biopsy report

180

1.79

2.47

1.3

1.5

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

469

0.55

2.46

2.0

1.7

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

352

1.55

2.41

1.0

1.1

2.00

1.32

u/ml

0.18

154

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

110

2.01

2.41

4.9

6.7

—

(3000034) Microalbumin [Mass/volume] in Urine

167

1.81

2.40

3.5

3.3

83.65

37.66

mg/l

0.30

129

(3012441) Differential panel - Pleural fluid

182

1.77

2.39

1.5

1.4

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

626

1.40

2.38

1.6

2.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

2.62

2.36

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

2.62

2.36

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

2.62

2.36

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

2.62

2.36

1.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

418

3647

1.18

2.35

3.3

3.0

0.75

ug/l

0.02

306

2400

(3020876) Protein [Mass/time] in 24 hour Urine

206

1.71

2.34

2.4

2.5

2.95

1.35

g/24h

0.77

107

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

578

1.42

2.33

1.8

—

(3014007) Fractional oxyhemoglobin in Arterial blood

152

1197

1.29

2.30

11.6

9.9

93.45

94.00

0.56

152

1190

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

405

1.49

2.30

1.2

1.1

0.73

2.88

u/ml

3.17

215

(3025130) Human papilloma virus identified in Specimen

277

1.60

2.29

2.0

1.8

—

(3032057) Clostridioides difficile [Presence] in Stool

2.95

2.28

1.3

2.0

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

341

1.54

2.28

1.0

1.1

—

(3019174) dRVVT (LA screen)

3.49

2.27

1.0

1.1

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

374

1.51

2.26

1.8

1.6

—

(3051651) Icteric interference index of Serum or Plasma

120

1.93

2.25

4.3

3.7

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

113

1.96

2.25

1.2

1.3

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

599

1.40

2.25

1.3

1.4

10.74

9.63

u/l

0.36

483

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

271

2286

1.21

2.23

5.2

6.7

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

2.10

2.22

2.5

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

2.20

2.21

1.1

2.2

27.25

28.47

0.16

(3028308) Erythrocytes [#/volume] in Pleural fluid

187

1.72

2.21

1.4

37362.67

77317.99

e6/l

0.47

108

(3014271) Vancomycin [Susceptibility]

2.13

2.18

3.5

2.6

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

151

1197

1.28

2.18

11.6

9.8

0.59

0.67

1.57

151

1187

(3023323) Follitropin [Units/volume] in Serum or Plasma

128

993

1.30

2.18

1.4

21.96

27.41

iu/l

1.20

106

839

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

3.34

2.18

1.3

1.0

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

3.69

2.15

3.6

4.4

—

(3021788) Differential panel - Synovial fluid

347

1.51

2.12

1.4

1.6

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

130

1.85

2.12

1.3

1.2

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

228

1.63

2.11

2.5

—

(3016879) Cocaine [Presence] in Urine

744

1.34

2.11

1.5

2.0

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

397

1.47

2.10

1.1

1.3

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

565

1.39

2.09

1.9

1.7

45.44

40.26

nmol/l

0.88

547

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

341

1.51

2.07

1.1

1.63

1567.25

iu/ml

—

(3043409) Potassium [Moles/volume] in Arterial blood

567

0.63

2.06

3.6

4.2

3.98

3.89

mmol/l

0.93

560

(3021387) Prolactin [Units/volume] in Serum or Plasma

103

782

1.33

2.06

1.6

326.60

305.80

mu/l

0.27

703

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

132

1.83

2.03

1.3

1.2

—

(3000764) Benzodiazepines [Presence] in Urine

105

801

1.32

2.03

1.6

2.0

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

400

1.46

2.03

1.9

1.8

176.09

205.39

pmol/l

1.09

380

(3030981) Hyaline casts [#/volume] in Urine by Automated count

126

986

1.29

2.03

2.7

2.9

0.30

0.25

e6/l

0.19

121

959

(3006245) CD3-CD19+ cells/100 cells in Blood

2.11

2.02

1.1

2.2

12.06

9.57

0.61

(3016650) Hepatitis A virus Ab [Presence] in Serum

335

1.50

2.02

1.1

—

(3008898) HLA-B27 [Presence]

743

1.33

1.99

1.1

—

(3023183) Ammonium ion [Moles/volume] in Plasma

411

1.45

1.97

2.2

3.0

34.80

35.33

umol/l

0.07

374

(3023410) Appearance of Cerebral spinal fluid

217

1.62

1.97

1.3

1.7

—

(3003740) Influenza virus B Ag [Presence] in Specimen

354

1.48

1.95

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

127

1.82

1.94

1.2

1.1

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

2.97

1.93

2.4

1.4

—

(3002523) Influenza virus A Ag [Presence] in Specimen

355

1.47

1.93

1.1

—

(3028300) Cannabinoids [Presence] in Urine

105

809

1.31

1.91

1.5

2.0

—

(4062490) Immunoglobulin typing, IgG

188

1.66

1.91

1.2

1.3

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

150

1.74

1.90

1.3

1.1

—

(3042733) HLA Ab [Presence] in Serum

2.25

1.90

6.4

4.9

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

149

1202

1.26

1.90

11.7

9.7

1.29

1.37

0.27

149

1193

(3010726) Horse dander IgE Ab [Units/volume] in Serum

340

1.48

1.90

1.1

2.09

2.11

u/ml

0.01

176

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

173

1.68

1.89

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

173

1.68

1.89

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

173

1.68

1.89

1.6

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

689

1.33

1.88

1.4

1.3

—

(3003434) Protein [Mass/volume] in Pleural fluid

228

1.59

1.87

1.4

32.06

31.88

g/l

0.03

205

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.65

1.86

1.0

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.65

1.86

1.0

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.65

1.86

1.0

1.1

—

(4094501) Cardiovascular stress test using bicycle ergometer

518

1.38

1.85

1.1

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

221

1.59

1.85

2.3

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

775

0.70

1.84

1.7

1.9

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

160

1.70

1.82

1.3

1.2

88.57

202.90

titre

—

(3027008) Opiates [Presence] in Urine

104

807

1.30

1.82

1.5

2.0

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

166

2008

0.81

1.81

3.3

3.2

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

295

1.50

1.80

1.4

27.34

25.82

u/l

0.11

243

(3016018) Differential panel - Cerebral spinal fluid

207

1.60

1.80

1.2

1.5

—

(3044009) aPTT.lupus sensitive (LA screen)

3.05

1.80

1.0

1.2

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

215

1.59

1.79

1.3

1.2

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

499

0.64

1.79

1.3

1.5

—

(3044889) 12 lead EKG panel

1435

13734

1.11

1.76

3.7

3.6

—

(3016502) Oxygen saturation in Arterial blood

226

1922

1.19

1.74

9.2

8.5

94.97

95.74

1.19

218

1848

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

3.85

1.71

1.4

1.2

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

492

1.37

1.71

1.3

1.2

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

179

1.63

1.69

1.1

1.0

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

275

1.50

1.69

2.3

6.58

7.02

umol/l

0.10

199

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

333

1.45

1.68

1.3

1.2

2.56

3.28

u/ml

0.37

119

(3051387) C reactive protein [Mass/volume] in Capillary blood

418

0.62

1.68

3.7

22.55

25.13

mg/l

0.14

273

(3006922) Hepatitis E virus Ab [Presence] in Serum

126

1.75

1.68

1.0

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

149

1.68

1.67

1.9

1.4

72.28

80.99

umol/l

1.81

149

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

157

1.66

1.65

1.2

1.1

—

(3051593) INR in Capillary blood by Coagulation assay

1.98

1.64

7.2

14.1

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

120

966

1.25

1.60

3.4

3.2

99.59

50.08

u/ml

0.68

113

933

(1761482) Bacteria [#/volume] in Urine by Culture

459

0.65

1.57

6.6

4.4

—

(40767503) Oxygen content in Capillary blood by calculation

383

0.62

1.52

3.5

2.5

16.68

16.25

0.23

192

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

3.34

1.52

1.2

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

3.34

1.52

1.0

1.1

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

2.16

1.50

1.1

1.2

292.20

307.58

pmol/l

—

(3003338) MCHC [Mass/volume]

1780

17292

1.11

1.48

23.2

17.1

331.99

332.63

g/l

2.40

1768

17163

(3038515) Glucose [Moles/volume] in Venous blood

380

0.63

1.48

5.9

3.3

7.70

7.55

mmol/l

0.08

371

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

139

1.66

1.48

2.0

1.4

147.88

233.08

pmol/l

0.64

139

(3048879) Bone marrow aspiration report

2.12

1.44

1.7

2.2

—

(3042517) Benzodiazepines panel - Urine

3.13

1.44

1.2

1.8

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

693

0.73

1.43

1.5

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

1.82

1.41

1.3

1.9

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

554

1.31

1.40

2.0

1.7

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

263

0.57

1.39

1.7

1.6

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

670

1.28

1.38

1.3

216.78

224.87

miu/ml

0.07

311

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

158

1.59

1.37

1.2

1.67

1.16

u/ml

0.15

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

264

1.45

1.36

1.2

1.3

—

(3027944) Amphetamines [Presence] in Urine

797

1.25

1.36

1.5

1.9

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

395

0.65

1.35

3.1

3.5

3.72

4.13

e9/l

0.78

395

(3045683) HLA typing for celiac disease panel - Blood or Tissue

112

1.70

1.35

1.1

1.0

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

540

1.31

1.34

1.4

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

265

1.44

1.34

1.1

11.30

5.79

u/ml

0.45

110

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

0.00

1.34

0.0

1.2

—

135.57

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

120

1.67

1.34

1.1

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

120

1.67

1.34

1.1

1.0

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

2.15

1.33

1.8

2.2

20.02

17.83

umol/l

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

2.15

1.33

1.1

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

128

1.65

1.33

1.4

1.5

18.80

21.53

u/ml

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

541

1.30

1.33

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

542

1.30

1.31

1.4

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1139

0.80

1.31

1.8

1.7

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

516

1.31

1.2

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

543

1.30

1.4

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

193

1.51

1.29

1.6

1.7

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

1.76

1.29

1.1

1.2

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

2.78

1.28

2.2

10.7

—

(3044941) Cell count panel - Synovial fluid

311

1.39

1.26

1.4

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

115

1.66

1.24

1.9

2.8

41.94

41.57

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

329

1.37

1.24

1.5

1.6

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

329

1.37

1.24

1.5

1.6

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

2.40

1.24

7.0

9.2

4.85

6.24

mmol/l

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

433

1.32

1.24

1.9

1.3

—

14.90

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

1.86

1.24

2.1

2.3

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

409

0.68

1.22

4.1

3.8

52.89

57.18

0.81

409

(3025018) Bordetella pertussis Ab [Titer] in Serum

116

1.64

1.21

1.2

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

280

1.40

1.20

1.1

1.50

1.52

g/l

0.18

255

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

140

1.58

1.20

1.1

2.2

11.50

15.18

0.94

135

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

2.31

1.18

1.3

1.0

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

2.31

1.18

1.2

1.0

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

239

1.43

1.18

1.1

1.3

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

291

1.38

1.15

1.1

8.78

3.88

u/ml

0.84

141

(3020393) Adenovirus Ag [Presence] in Stool

2.50

1.15

1.0

1.4

—

(3019832) Treponema pallidum Ab [Presence] in Serum

235

2082

1.14

1.15

1.8

1.7

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

1.81

1.15

2.4

2.6

—

(1175426) CD3 cells/100 lymphocytes in Blood

142

1.55

1.14

1.1

2.2

76.50

72.60

0.85

135

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

233

1.42

1.13

1.1

91.61

96.47

0.50

221

(3012494) Peanut IgE Ab [Units/volume] in Serum

1.90

1.12

1.2

1.1

4.81

0.78

u/ml

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

2.00

1.12

1.3

1.5

—

166.29

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

111

1.63

1.12

1.2

1.7

6.53

9.94

ug/l

0.85

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

184

1.47

1.11

3.2

2.6

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

424

1.30

1.10

1.9

1.4

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

2.38

1.09

1.0

—

(3010421) pH of Blood

502

0.73

1.09

3.6

4.1

7.41

7.42

1.17

447

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

434

1.30

1.08

1.8

1.5

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

444

1.29

1.07

1.6

1.2

—

(3052592) Norovirus Ag [Presence] in Stool

2.12

1.05

1.1

1.5

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

2.12

1.05

1.1

1.2

—

(3012501) Base excess in Blood by calculation

418

0.71

1.05

3.7

4.4

2.48

2.58

mmol/l

0.10

279

(3020191) Ethanol [Moles/volume] in Serum or Plasma

154

1.50

1.03

1.3

1.4

1.45

1.23

promille

0.29

125

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.96

1.03

1.2

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.28

1.03

1.0

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.06

1.03

1.0

1.2

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

324

1.33

1.02

1.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

130

1114

1.18

1.01

1.4

1.3

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

155

1.49

1.01

1.0

1.1

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

226

0.62

1.01

4.7

2.7

—

(3001186) Copper [Moles/volume] in Serum or Plasma

1.88

1.00

1.1

1.3

18.67

16.95

umol/l

—

(3020891) Body temperature

740

0.79

1.00

3.8

4.7

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

131

1.53

0.99

1.1

2.2

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

123

1.55

0.99

1.4

1.8

—

(1617658) Protocol used for examination of sentinel lymph nodes

157

0.57

0.98

1.0

1.1

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

2.18

0.98

1.8

1.5

87.60

116.62

ng/l

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

2.18

0.98

1.6

1.9

—

(3032868) Hemoglobin electrophoresis panel in Blood

2.18

0.98

2.0

1.5

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.95

0.97

1.0

1.1

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.80

0.96

2.1

2.6

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.80

0.96

2.1

2.6

—

(3006653) Thiamine [Moles/volume] in Blood

108

1.58

0.96

1.4

131.76

138.33

nmol/l

0.24

108

(3051101) Glucose [Moles/volume] in Cord blood

0.00

0.96

0.0

6.1

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

425

1.28

0.96

3.3

2.2

0.95

0.83

nmol/l

0.22

355

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

328

1.32

0.96

1.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

150

1.47

0.93

2.3

1.7

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

184

1.42

0.91

1.1

1.7

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

518

1.24

0.91

1.7

1.9

4.46

4.96

iu/l

0.14

186

(3019060) Gas panel - Arterial blood

105

1229

0.85

0.91

4.0

5.3

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

244

1.36

0.91

1.0

1.1

3.38

0.38

u/ml

—

(3022621) pH of Urine by Test strip

145

1268

1.15

0.90

2.6

2.7

—

(3013293) Extractable nuclear Ab [Presence] in Serum

2.07

0.89

1.8

1.6

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.91

0.88

1.4

1.3

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

289

1.32

0.88

1.2

1.1

7.39

2.18

u/ml

1.09

136

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

2.00

0.87

1.0

1.1

—

(21494434) Karyotype in Bone marrow

178

1.41

0.86

1.3

1.2

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

807

1.18

0.85

2.3

2.1

2576.05

4562.87

u/l

0.43

322

(40768795) Lymph node Pathology biopsy report

179

0.61

0.84

1.1

1.2

—

(3011985) Renin [Units/volume] in Plasma

239

1.34

0.84

1.6

1.4

56.14

43.90

mu/l

0.19

217

(3037692) Legionella sp identified in Specimen by Organism specific culture

1.70

0.82

1.2

1.5

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

562

1.22

0.82

2.8

3.5

24.88

72.54

mg/l

1.32

452

(3008295) Osmolality of Serum or Plasma

197

1.37

0.82

1.2

1.4

287.05

280.67

mosm/kgh2o

0.72

150

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

526

1.22

0.81

1.1

1.3

485.41

508.31

mg/l

0.14

494

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

1.55

0.81

1.5

1.6

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

1.55

0.81

1.5

1.6

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

591

1.21

0.80

1.4

1.5

—

(3035350) Ketones [Presence] in Urine by Test strip

1005

9688

1.06

0.80

3.6

3.5

0.00

estimate

0.75

130

1977

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

0.79

0.0

1.0

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

384

1.26

0.78

2.7

3.4

40.91

1048.30

u/ml

0.89

358

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

131

1.45

0.78

1.0

1.1

0.66

3.48

nmol/l

—

(3032773) Endomysium IgG Ab [Titer] in Serum

182

1.38

0.77

1.0

1.1

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

0.00

0.77

0.0

1.2

—

(3044242) Glucose [Moles/volume] in Arterial blood

100

0.50

0.77

1.4

2.5

—

(3037756) Immunofixation for Serum or Plasma

376

1.25

0.77

1.2

1.6

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

217

1.34

0.77

1.7

1.6

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

702

0.82

0.76

1.3

1.4

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

2.09

0.74

1.2

1.3

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

561

1.20

0.73

2.9

3.5

51.43

68.23

mg/l

0.41

450

(40761535) Cells panel - Urine sediment

171

1538

1.12

0.73

3.6

3.3

—

(3003181) Sodium [Moles/volume] in Urine

317

1.27

0.72

1.6

1.4

62.26

63.44

mmol/l

0.06

262

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.67

0.72

1.2

1.4

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.62

0.71

1.3

1.6

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

247

2269

1.10

0.71

1.9

1.7

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

328

1.25

0.69

1.5

0.44

0.35

nmol/l

0.54

260

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

204

1.33

0.69

1.1

1.2

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.85

0.68

2.8

2.3

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

120

0.58

0.67

1.6

1.5

—

(3021601) Nitrite [Presence] in Urine by Test strip

999

9669

1.06

0.67

5.3

4.7

0.00

estimate

0.50

129

1884

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.63

0.66

1.0

1.1

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

0.53

0.66

1.2

1.4

—

4.55

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

223

1.30

0.66

1.6

1.4

332.24

337.14

pmol/l

0.02

194

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.79

0.66

1.0

1.2

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

605

1.18

0.66

1.6

23.39

10.94

iu/ml

0.20

111

(40757373) Influenza virus identified in Isolate

1.59

0.65

1.3

1.6

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

486

1.20

0.65

4.0

3.2

24.49

24.73

mmol/l

0.26

475

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

1.48

0.64

1.2

1.1

185.74

215.20

iu/ml

0.20

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.73

0.64

2.8

2.3

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

738

1.16

0.63

2.1

2.0

2.00

1.77

ug/l

0.11

656

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

1.59

0.61

1.9

1.5

14.00

13.72

pmol/l

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

262

1.26

0.61

1.2

1.5

—

(3011648) Oxygen content in Venous blood

156

1.35

0.61

2.5

4.2

11.00

11.18

0.07

156

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

323

0.77

0.60

1.4

1.3

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

209

1.30

0.60

1.0

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

172

1570

1.10

0.59

3.8

2.5

67.61

68.43

ml/min/173m2

0.10

583

(3000093) Morphology [Interpretation] in Blood Narrative

166

1.33

0.58

1.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.00

0.58

0.0

1.3

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

231

0.73

0.58

1.5

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

231

0.73

0.58

1.5

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

660

1.16

0.58

2.8

3.4

103.11

5984.68

u/ml

0.79

559

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

466

1.18

0.57

1.5

1.6

—

(3039443) Prostate specific Ag panel - Serum or Plasma

363

0.80

0.56

1.7

—

(4034850) Laboratory test

634

0.85

0.55

11.6

9.4

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

160

0.69

0.55

1.9

1.6

7.45

7.66

mmol/l

0.14

153

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

1.54

0.55

1.0

1.4

—

90.47

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

133

1.36

0.55

1.0

776.92

719.09

ng/l

0.20

(3045788) Cell count panel - Pleural fluid

168

1.31

0.55

1.6

1.4

—

(3000012) Reticulocyte production index

250

0.76

0.54

3.0

2.2

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

134

1.35

0.53

1.0

39.39

45.22

ng/l

0.35

(3009261) Glucose [Presence] in Urine by Test strip

1004

9770

1.05

0.53

3.7

3.5

0.03

0.00

estimate

0.37

120

1805

(3024932) HLA-DR beta [Type]

1.43

0.52

1.2

1.1

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

0.61

0.52

1.7

1.6

—

(3034426) Prothrombin time (PT)

1.41

0.51

1.6

1.3

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.41

0.51

1.0

—

(3024471) HLA-A [Type]

1.41

0.51

1.0

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

233

1.25

0.51

1.0

1.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

247

0.77

0.50

1.4

1.1

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

1.49

0.49

1.0

1.1

—

91.66

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.46

0.46

1.0

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

164

1.28

0.46

1.3

1.4

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

328

1.19

0.46

1.6

1.7

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

142

0.70

0.46

1.6

—

(3005033) Fetal Nuchal fold Thickness US

440

1.16

0.45

1.4

—

(1616796) Gas panel - Central venous blood

406

0.84

0.45

4.0

3.8

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

422

1.16

0.45

1.7

1.3

198.16

250.35

u/ml

1.16

251

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

469

1.15

0.44

2.2

2.3

103.61

110.23

ug/min

0.05

295

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

186

0.75

0.44

1.1

1.5

17.00

30.78

—

118

(3050129) First trimester maternal screen panel - Serum or Plasma

677

1.13

0.44

1.6

1.4

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

238

1.22

0.44

1.0

1.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

211

1.23

0.43

1.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

811

1.11

0.43

1.5

1.7

3.55

4.22

mg/l

0.31

592

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

1.61

0.43

1.0

2.2

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.61

0.43

1.4

1.5

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.61

0.43

1.0

1.2

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

443

1.15

0.42

1.4

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

0.66

0.42

1.2

1.4

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

122

1.31

0.42

1.0

29.72

1.01

u/ml

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

173

0.75

0.42

1.3

2.0

18.83

20.17

nmol/l

0.19

162

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

0.00

0.41

0.0

1.0

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

0.00

0.41

0.0

1.1

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.41

0.0

5.7

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

0.00

0.41

0.0

1.8

—

0.44

—

(3001729) Color of Synovial fluid

0.00

0.40

0.0

1.8

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

1.39

0.40

3.1

4.0

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

133

1.28

0.38

1.0

294.25

309.85

ng/l

0.12

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

335

1.17

0.38

1.3

1.5

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

322

0.84

0.37

1.4

1.6

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

519

5019

1.04

0.37

4.1

4.3

22.94

21.51

1.17

240

2429

(3014148) Varicella zoster virus Ab [Titer] in Serum

253

1.19

0.36

1.1

1.2

—

(3021901) Oxygen saturation in Capillary blood

342

0.85

0.35

3.7

3.0

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1034

0.92

0.35

1.4

1.5

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

200

0.80

0.34

1.6

1.7

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

425

0.87

0.33

2.5

2.2

131.43

130.32

g/l

0.08

314

(3028679) Herpes simplex virus Ab [Presence] in Serum

109

1.29

0.33

1.1

1.2

—

(3006462) Nitrate [Presence] in Urine

0.70

0.33

3.2

2.7

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

275

1.17

0.32

2.0

2.6

6.17

206.74

u/ml

0.75

270

(3043238) Trisomy 21 risk [Likelihood] in Fetus

455

1.12

0.32

1.4

1.5

—

(3042631) Mycobacterium sp identified in Specimen

248

1.17

0.31

2.6

2.7

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

0.71

0.30

1.6

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

100

0.70

0.30

1.1

1.4

—

65.67

—

(3000330) Specific gravity of Urine by Test strip

102

947

1.08

0.30

3.9

3.4

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

240

1.17

0.30

1.1

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

890

0.92

0.30

4.4

3.3

24.64

25.26

mmol/l

1.01

858

(3015183) Erythrocyte sedimentation rate

108

0.74

0.29

1.4

1.2

—

(3017704) Immunofixation for Urine

108

0.74

0.29

1.0

1.7

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

179

1884

0.95

0.28

1.8

1.7

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

416

4031

1.04

0.28

1.7

50755687.63

33697040.49

pmol/l

0.19

331

3395

(3035933) Granulocytes/100 leukocytes in Blood

1.25

0.27

1.1

1.4

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.23

0.27

1.0

1.1

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

1.23

0.27

1.1

1.5

53.50

183.00

nmol/24h

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

1.17

0.24

1.1

1.2

—

(3036071) Salmonella sp Ab [Titer] in Serum

0.72

0.24

1.2

1.0

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

115

1.22

0.23

1.0

1.1

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

466

1.10

0.23

1.2

1.5

17.95

30.57

e6/l

0.33

362

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

466

1.10

0.23

1.2

1.5

107.63

1167.27

e6/l

1.14

379

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

332

1.12

0.23

4.9

3.0

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

0.75

0.22

3.4

2.7

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.21

0.0

1.0

—

(3004959) Base excess in Arterial cord blood by calculation

0.00

0.21

0.0

1.0

—

(3006598) pH of Arterial cord blood

0.00

0.21

0.0

1.0

—

(42870560) Thyrotropin [Units/volume] in Cord blood

0.00

0.21

0.0

1.0

—

18.40

—

(3015956) Eosinophils/100 leukocytes in Blood by Manual count

0.00

0.21

0.0

2.1

—

2.10

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.00

0.21

0.0

3.5

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

182

1.16

0.21

1.6

2.4

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(40760888) Immunoglobulin light chains.free panel - Serum

421

1.09

0.21

3.4

3.7

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

0.00

0.21

0.0

1.7

—

21.67

—

(21491868) Cryoglobulin [Mass/volume] in Serum

1.25

0.20

1.0

1.2

—

0.06

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

288

1.11

0.20

1.1

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

127

1.18

0.19

1.0

1.1

0.88

1.06

u/l

—

(4281824) Cell count and differential, peritoneal fluid

193

1.14

0.19

1.1

1.2

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.18

0.19

1.0

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

146

1.17

0.19

1.0

1.2

—

(3019150) Specific gravity of Urine by Refractometry

412

4213

0.97

0.18

3.5

3.8

1.02

kg/l

0.41

603

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

156

1.15

0.18

1.4

2.2

0.60

1.94

u/field

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

109

1.19

0.18

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.17

0.17

1.4

7.51

9.31

ug/l

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.17

0.17

1.0

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.15

0.17

1.0

1.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

322

3298

0.97

0.17

1.4

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

1.14

0.15

1.0

—

(3010838) Calcium [Moles/time] in 24 hour Urine

342

1.08

0.15

2.3

2.0

3.94

5.14

mmol/24h

1.75

301

(3002079) Sodium [Moles/time] in 24 hour Urine

0.81

0.14

1.3

129.71

168.30

mmol/24h

—

(3047189) Immunofixation for 24 hour Urine

0.79

0.14

1.6

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

451

1.07

0.13

1.6

—

(44813793) Dust mix specific IgE antibody measurement

132

1.14

0.13

1.0

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

238

1.09

0.13

1.1

1.6

65.36

60.89

0.19

152

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

384

1.07

0.12

1.5

1.4

—

(40768800) Prostate Pathology biopsy report

384

1.07

0.12

1.2

—

(3035880) pH of Pleural fluid

104

1.15

0.12

1.2

1.3

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

123

1271

0.97

0.12

1.5

1.4

—

(3025159) Blasts/100 leukocytes in Blood

143

1470

0.97

0.11

5.3

4.1

0.04

0.53

0.94

376

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

1.16

0.11

1.5

2.3

16.44

113.95

ug/l

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

126

1.11

0.09

1.0

1.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

134

0.90

0.08

1.9

1.5

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

351

1.05

0.08

3.3

3.1

0.83

nmol/l

0.01

273

(3021440) Promyelocytes/100 leukocytes in Blood

159

1557

1.02

0.08

5.1

4.1

0.04

0.12

1.20

461

(3006576) Bicarbonate [Moles/volume] in Blood

1.03

0.08

10.5

5.9

22.03

25.52

mmol/l

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

144

0.90

0.08

1.4

1.6

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

0.82

0.08

1.0

1.1

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

224

1.07

0.08

1.1

1.3

—

nmol/l

—

(21494890) Protein electrophoresis panel - 24 hour Urine

195

0.92

0.08

2.0

2.2

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.08

0.08

1.0

1.1

—

(40765096) Chromosome analysis panel by Banding

1.08

0.08

1.0

1.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

1.04

0.08

1.0

1.3

—

(21494814) CD8 cells/100 lymphocytes in Specimen

0.86

0.07

1.2

2.2

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

0.86

0.07

1.0

1.2

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

0.86

0.07

1.0

1.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

0.83

0.07

1.0

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

1.04

0.07

1.1

1.2

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

153

0.91

0.07

1.3

1.5

0.96

0.97

g/l

0.05

153

(3047181) Lactate [Moles/volume] in Blood

609

0.97

0.06

5.4

6.9

1.43

1.33

mmol/l

0.47

525

(3024263) Appearance of Synovial fluid

102

0.88

0.06

1.1

1.5

—

(3003694) ABO and Rh group [Type] in Blood

580

5761

1.01

0.06

1.4

1.5

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

168

1.07

0.06

3.1

3.4

29.76

46.58

u/ml

0.51

168

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

819

0.98

0.05

4.8

3.8

53.32

48.67

0.85

808

(3004775) Volume in Urine collected for unspecified duration

161

0.93

0.05

2.2

656.78

623.24

—

107

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

262

0.95

0.04

1.3

1.5

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

130

1.08

0.04

1.6

1.5

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

1.10

0.04

1.1

1.2

—

(3017181) Myelocytes/100 leukocytes in Blood

162

1636

0.99

0.03

5.1

4.0

0.91

0.92

0.02

541

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

300

1.03

0.03

1.3

1.4

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

128

0.94

0.02

1.2

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

128

0.94

0.02

1.2

1.3

1.54

1.56

g/l

0.06

128

(3010144) Erythrocytes [#/volume] in Synovial fluid

188

0.96

0.02

1.1

1.4

5791.00

108574.42

e6/l

—

129

(3002179) Metamyelocytes/100 leukocytes in Blood

151

1498

1.01

0.02

4.8

3.9

0.98

0.63

0.36

468

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

1.08

0.02

1.0

1.1

1411.39

1648.49

miu/ml

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

368

0.98

0.01

1.9

1.7

—

(3045142) Bone marrow Pathology biopsy report

217

0.97

0.01

1.5

1.4

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

210

2094

1.00

0.00

1.4

—

(40768441) Liver Pathology biopsy report

145

1.03

0.00

1.2

1.3

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

101

0.99

0.00

1.2

1.1

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

159

1.01

0.00

2.6

1.9

3.69

4.28

mg/l

0.29

152

(40768793) Breast Pathology biopsy report

429

1.00

0.00

1.4

1.3

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

116

1.03

0.00

1.6

1.7

—

(3020874) Milk IgE Ab [Units/volume] in Serum

116

1.03

0.00

1.0

1.1

0.16

2.49

u/ml

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

1.02

0.00

1.2

2.8

521.60

1274.51

u/ml

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

137

1.02

0.00

1.1

1.2

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.0

1.0

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

(3013336) Amino acids [Identifier] in Serum or Plasma

0.00

0.0

4.2

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

0.0

5.0

—

382.83

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

0.0

1.2

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

0.00

0.0

1.0

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

(3044336) Cobalt [Moles/volume] in Urine

0.00

0.0

2.0

—

17.84

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

1.7

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.2

—

1.20

—

(3040661) Urea [Moles/volume] in Peritoneal dialysis fluid

0.00

0.0

5.0

—

17.37

—

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

0.00

0.0

1.0

—

1.00

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

-0.00

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3004451) EKG impression Narrative

0.94

-0.00

1.1

1.3

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

0.99

-0.00

1.3

1.2

107.00

108.28

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.9

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3028433) Virus identified in Specimen by Culture

0.97

-0.00

1.2

1.3

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

0.93

-0.00

1.1

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3041806) Other cells [#/volume] in Blood by Manual count

0.89

-0.00

1.0

1.5

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.02

-0.00

1.0

1.3

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

110

1.00

-0.00

1.7

1.6

2.83

3.71

u/field

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.4

—

2.43

—

(3011325) HIV 1+2 Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3008607) Semen analysis panel

0.00

-0.00

0.0

1.3

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

0.98

-0.00

1.6

1.1

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

-0.00

0.0

1.3

—

2.56

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint H8_EXT_INFNAS and mortality.

Females

Parameter	HR [95% CI]	p-value
H8_EXT_INFNAS	1.229 [1.08, 1.4]	0.001
Birth year	0.996 [0.99, 1.0]	0.402

During the follow-up period (1.1.1998 — 31.12.2019), 922 out of 7274 females with H8_EXT_INFNAS died.

Males

Parameter	HR [95% CI]	p-value
H8_EXT_INFNAS	1.296 [1.15, 1.46]	< 0.001
Birth year	0.99 [0.98, 1.0]	0.025

During the follow-up period (1.1.1998 — 31.12.2019), 1222 out of 6899 males with H8_EXT_INFNAS died.

Mortality risk

Mortality risk for people of age

years, who have H8_EXT_INFNAS.

N-year risk	Females	Males
1	0.084%	0.247%
5	0.761%	1.604%
10	1.791%	4.07%
15	3.653%	7.977%
20	6.526%	13.166%

Relationships between endpoints

↥

Index endpoint: H8_EXT_INFNAS – Other infective otitis externa

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other infective otitis externa

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints